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1. INTRODUCTION 
1.1 GENERAL 
The use of enzymes in organic chemistry has become accepted 
practice during the last fifteen years, and many laboratories are now using 
them to introduce functional groups into organic molecules. Enzymes have 
the unique ability to catalyze reactions that would otherwise be difficult (if 
not impossible) to perform with conventional chemical methods. Moreover, 
these reactions have a high rate, a high specificity, and can be performed 
under mild conditions. 
Enzymatic capabilities have been a major topic of research in this 
University's Department of Organic Chemistry since 1975. Experiments 
have, for example, used enzymes in regio-specific conversions of 
azaheterocyclic compounds. These reactions involved studying the 
biocatalysts bovine milk xanthine oxidase [1], bacterial xanthine oxidase [2], 
chicken liver xanthine dehydrogenase [3], rabbit liver aldehyde oxidase [4], 
and haloperoxidases [5]. Experiments with the xanthine oxidase used the 
azaheterocycles 6-aryl-substituted pteridin-4-one, 7-aryl-substituted 
pteridin-4-one, 7-aryl-substituted linear-benzo derivative of pteridin-4-one, 
and 1-aryl-substituted nicotinamide [6]. 
In the Department's work, if enzymes are used as catalysts, the 
organic molecules act as enzyme substrates. In other types of research, the 
organic molecules act as inhibitors of an enzymatic reaction. Inhibitors have 
become important research tools in biochemistry, biophysics, medicine, 
and pharmaceutics. They are used to study specific intracellular functions 
and elucidate the mechanism of ligand binding, the process of enzymatic 
catalysis, and the structure of the enzymatic active site. A favored goal of 
anti-parasite and anti-cancer chemotherapy is the inhibition of an enzyme 
essential to bacterial growth or tumor-like cell division. Partial or total 
inhibition of a mammalian enzyme to control the functioning of specialized 
cells (e.g. of the brain and nervous system) is a specific goal of medicinal 
chemistry. 
The first step in designing therapeutic or pharmaceutical compounds 
is to identify a target enzyme that, when inhibited, will produce the desired 
effect without toxic side effects. After the target enzyme has been identified, 
a strategy to find and synthesize an effective inhibitor must be planned. 
Even though many of the enzyme inhibitors now widely used as medicines 
were found by trial and error, it is estimated that this method produces only 
one useful drug for every three to five thousand compounds synthesized [7]. 
Recent discoveries, however, have provided a more ra t ional bas i s for 
designing enzyme inhibitors. 
Biological activity is no longer considered solely a function of chemical 
s t r u c t u r e . Nowadays, it is a recognized function of phys icochemica l 
propert ies . This h a s led the way to the development of a re la t ionship 
between the s t ructure and biological activity of a compound. The ult imate 
goal in the s tudy of tha t relationship is the realization of a "tailor-made" 
bioactive molecule. 
1.2 A SHORT HISTORY OF QUANTITATIVE STRUCTURE-ACTIVITY 
RELATIONSHIP (QSAR) STUDIES 
Researchers have been using physicochemical properties to s tudy the 
biological activity of organic compounds since the 1880's. Even at tha t early 
date, the researchers realized that , because of its reliance on s t ruc tu ra l 
formulas, the language of synthetic organic chemistry was not the most 
sui table one for unders tanding structure-activity relat ionships (SAR's) [8]. 
Accordingly, those first s tud ies , which compared only one molecular 
property with the biological activity, were often unsuccessful. 
Over the last thirty years, it has become clear t ha t the biological 
activity of a compound may depend on more t h a n one physicochemical 
p roper ty (or o ther process) of the biological object. These inc lude 
permeat ion and t ranspor t , d rug metabolism, and in teract ion with the 
biological organism. This thesis limits discussion of the SAR to the physical 
and physicochemical properties of an organic compound; permeat ion and 
transport , and drug metabolism in the SAR fall outside of its scope. 
An SAR s tudy has two purposes , namely prediction and diagnosis. 
Prediction, as the word implies, is the extrapolation and interpolation of a 
correlation study. In a correlation study, one tries to optimize the bioactivity 
of a compound by varying the substi tut ion pat tern in a congeneric group of 
compounds. Research in physical organic chemistry h a s added significantly 
to the unders tanding of subs t i tuent properties. Diagnosis is an a t tempt to 
answer quest ions about the interaction between drugs and receptors. New 
tools (e.g. X-ray analysis, high-resolution nuclear magnetic-resonance 
spectroscopy, electron spin-resonance spectroscopy, and computer-aided 
molecular graphics) have greatly facilitated the study of the interaction 
between small organic compounds and biological macromolecules like 
enzymes and DNA [9], The ultimate objective of diagnosis is the rational 
development and designing of entirely new classes of compounds for 
specific biological activities. 
The SAR study came into its own in the 1960's, as computers were 
becoming widely available. For the first time, it was possible to use more 
than one parameter in an SAR study and calculate a quantitative relationship 
between a biological activity and the parameters describing a congeneric 
group of compounds. Since then, numerous methods for studying 
quantitative structure-activity relationships (QSAR's) have been developed 
and commonly applied. These include the nonparametric methods of Free 
and Wilson [10] and Fujita and Ban [11], the parametric method of Hansen 
and co-workers [12], discriminant analysis [13], and pattern recognition 
[14]. 
The choice of a method depends on several factors (e.g. the quality of 
biological data, the number of compounds tested, the degree of variance in 
the results, and the ratio of the time required for synthesis and biological 
testing). The most widely used method is the linear free-energy approach, 
also known as the Hansch approach [12]. It attributes variation in a 
biological activity (BA) to the different substi tuents whose different 
physicochemical properties modify a BA relative to the parent compound. 
These properties can be translated into parameters and then added and 
combined. The parameters are adopted from physical chemistry and are 
assumed to be electronic, steric, hydrophobic, and dispersive (see Table 
1.1). A more detailed discussion follows in the next section. 
The most widely used substituent parameters are the Hammett 
constant (a), the Taft steric constant (Es), the hydrophobic constant (rc), 
and the molar refractivity (MR). Although Hansch and Leo [15] have 
tabulated the values of many substitution constants, the data base is far from 
complete. The Hansch approach results in the following equation: 
BA = a + D7i + co + dE s + eMR (1.1) 
Table 1.1 Linear Free-Energy-Related Parameters 
Parameter Name Description Ref. 
HYDROPHOBIC PROPERTIES 
p 
7t 
RM 
k' 
Partition 
coefficient 
Hydrophobic 
constant 
Hydrophobic 
constant from 
chromatography 
Hydrophobic 
constant from 
HPLC 
ELECTRONIC PROPERTIES 
" ( % 
a 
•KJT 
Op) Hammett 
constant 
Taft constant 
Resonance and 
Field constants 
pKa Ionization 
constant 
DISPERSION PROPERTIES 
MR Molar 
refractivity 
STERIC PROPERTIES 
Es Taft steric 
constant 
Log P, taken as a measure of the hydrophobicity of the molecule; 16,17 
to measure P, it is best to use an octanol-water system. 
7i = log Px - log R[_|. where Px is the partition coefficient of the 17 
substituted compound, and P|_| the partition coefficient of the 
unsubstituted reference compound. 
Log P is linearly related to R^, as expressed by log P = R^ + a. 18 
Log P is linearly related to log k' (for reversed-phase systems), 19 
as expressed by log P = k' + a. 
Defined only for meta and para substituents in aromatic rings to 5 
represent electronic character; a positive value for a denotes an 
electron-withdrawing character, a negative value for o denotes an 
electron-donating character. 
Measure of the electronic effect produced by aliphatic substituents. 21 
<j involves the resonance effect (?0 and field (inductive) effect (?) 22 
of a substituent. In other words, a = a%.+ by; where a and b are 
constants, depending upon the type of c (am , op); »{.and ?"are more 
indicative of the intrinsic resonance and field effects of a substituent; 
the sign of î^and ^indicates the sign of the charge that the substituent 
would place on the ring. 
pKa = -log Ka, where Ka is the ionization constant of an acid. 
MR = [(T|2-1 )/(T|2+2)]MW/p, where T\ is the refractive index for the 23,24 
sodium D line, MW is the molecular weight, and p is the density of 
the compound; MR can be used as a steric parameter in the 
absence of Es; MR also measures the electronic effect and can 
reflect the dipole-dipole interaction at the active site. 
MV 
Vw 
r 
R 
L . B L 
Molar volume 
v.d.Waals 
volume 
v.d.Waals radius 
Interatomic distance 
Related to the acid-catalyzed hydrolysis of a-substituted acetates 
(XCH2COOR); it represents the steric effect influencing intramolecular 
and intermolecular hindrance to the reaction or binding. 
General steric bulk parameter. 
Steric bulk parameter based on Bondi radii. 
21 
B5 
MTD 
Sterimol 
parameters 
Molecular 
connectivity 
index 
Minimum 
topological 
difference 
Directional steric parameters, where L is a measure of the length 
of the substituent, B-| a measure of its smallest width, and B5 a 
measure of its largest width. 
Topological parameter defined to account for the effects of atoms, 
bonding types, adjacent spaces, branching patterns, unsaturation, 
and heteroatomic content in a molecule on the reactivity or activity 
of that molecule. 
Deviation from an optimum standard molecule. 
25 
26 
27 
28 
29 
30 
31 
where BA is the concentra t ion (C), t ha t is required to p roduce some 
s tandard biological response. BA is often expressed as the inverse of C, or as 
the logarithm of the inverse of C. The values of the coefficients a, b, c, d, 
and e in Equation 1.1 are fit by least-squares multiple-regression analysis. 
This method also provides a measure of: 
The t value, which gives an indication of the significance of the 
coefficient of each parameter; 
The value of the r 2 statistic, which is tha t fraction of the variance in 
the BA data that is explained by the equation; 
The s value, which is the standard deviation of the observed BA values; 
The F value, which is the ratio between the variances of the observed 
and the calculated BA values, and which indicates the significance of 
the total equation. 
After performing the multiple regression analysis, one examines the 
da ta set for in teres t ing equat ions (i.e. those t ha t conta in stat is t ical ly 
significant terms, make mechanist ic sense, and do not overfit the data). 
This last quality means that, in general, only one parameter is used for a 
minimum of three observed BA values. 
1.3 PARAMETERS USED IN QSAR ANALYSIS 
1.3.1 Hydrophobic Parameters 
Interest focused on the hydrophobic property of a compound when 
Meyer [32] and Overton [331 showed tha t the narcotic activity of many 
simple organic compounds paralleled their oil-water par t i t ion coefficient 
(P). In QSAR analysis, the logarithm of the parti t ion coefficient (log P) is 
commonly used as a hydrophobic parameter. Octanol-water solutes are now 
the s tandard reference system for measuring P [17]. 
Although log P is a measure of the hydrophobicity of a whole molecule, 
it is not unusua l to work with a congeneric group of compounds, in which a 
large portion of the s t ructure remains constant . In tha t case, one need not 
know the hydrophobicity of the entire compound; knowing only the relative 
hydrophobicity of the subs t i tuen t s can be enough to perform the QSAR 
analysis. To find the relative hydrophobicity of subs t i tuents , Leo et al. [17] 
and Fujita et al. [34] defined the hydrophobic constant (TC) analogous to the 
Hammett constant (o), in which: 
7tx = log PX - log P H (1.2) 
where P x is the partition coefficient of the substituted compound and PJJ is 
the partition coefficient of the parent compound. A positive value for n 
means that, relative to H, the substituent favors the octanol phase. A 
negative value indicates the substituent's hydrophilic character relative to H. 
1.3.2 Electronic Parameters 
Physical organic chemists are studying many electronic parameters 
that are based on linear free-energy relationships. In QSAR analysis, an 
important parameter is the Hammett constant [15], which is defined as: 
o = log K x - log KH (1.3) 
where KH is the ionization constant for benzoic acid in water at 25°C and 
K x is the ionization constant for both meta and para derivatives under the 
same experimental conditions. If o is positive, the substituent withdraws 
electrons from the aromatic ring. If it is negative, electrons are released to 
the ring. Presumably, the electronic effect has two components: a through-
bond electrostatic effect of the substituent on a reaction center (inductive 
effect) and a direct through-space electrostatic effect of the substituent on a 
reaction center (field effect). Taft [21] has defined the inductive constant 
a*, which is valid for aliphatic systems, and Swain and Lupton [22] have 
defined the resonance constant (3Ü and the new field constant (J). 
1.3.3 Dispersion Parameters 
Nonspecific interactions (e.g. the hydrophobic effect and dispersion 
forces) can be very important in biological activities. It is likely that 
nonspecific interactions are crucial in the early stages of substrate and 
receptor interaction, when the more specific stereoelectronic factors have 
not yet come into play. 
In their classic s tudy of the interaction of small organic compounds 
with macromolecules, Pauling and Pressman [35] reported tha t dispersion 
forces are related to molar refractivity (MR). This relationship is expressed 
as: 
3 a a a 1,1 
E = -
2 r 6 I a + I
" (1.4a) 
M R = 4 K M O Ç 
(1.4b) 
where E is the cohesive energy between two a toms (a and b), a is the 
polarizability of those atoms, r is the distance between a and b , and I is the 
ionization potential. Equation 1.4b shows the relationship between MR and 
a and, by extension, tha t between MR and E. In exper iments , MR is 
obtained with the Lorentz-Lorentz equation: 
*
 + 2 P
 (1.4c) 
where r\ is the refractivity index, p is the density, and MW is the molecular 
weight of a compound. Its relationship to MW makes MR a steric bulk 
parameter. Because MR is an additive-constitutive molecular property, it is 
possible to calculate fragment values for many common groups of a toms. 
Hansch et al. [23] have compiled an extensive listing of MR values. 
MR h a s not always been practical for QSAR analysis . If the set of 
congeners to be studied is not designed carefully, n and MR often tu rn out 
to be so highly collinear that they yield approximately the same correlation. 
1.3.4 Steric Parameters 
Researchers have been using the steric effects of subs t i tuents to s tudy 
organic reaction rates since the latter half of the n ineteenth century [36]. 
The first generally accepted numerical definition of steric effects was 
formulated by Taft [21]. It reads: 
E s = log (kx / k H ) A d-5a) 
where E s is the steric constant and k refers to the rate constant for the acid 
hydrolysis (A) of type I esters: 
X-CH2COOR 
I 
The acid hydrolysis method cannot be used with some substituents 
because the esters are not stable under experimental conditions. For those 
substituents, Kutter and Hansch [27] calculated E s with the following 
correlation equation: 
E s = -1.839 rv(av) + 3.484 (1.5b) 
where rv(av) is the average of the maximum and minimum van der Waals 
radii of the substituent, as estimated according to Charton [28]. 
Other descriptors of steric effects are the van der Waals volume (Vw) 
[26], the van der Waals radii [27], and the Molar volume [25a], all of which 
are based on the atomic radii calculated by Bondi [25b]. Also in this group is 
the molecular connectivity index (x) [30], which gives a quantitative 
description of molecule branching. Comparison of X with various steric 
parameters has, in some cases, revealed a strong intercorrelation [37], 
suggesting that X is also a measure of the substituent steric bulk. 
Despite the many descriptors, it is very difficult to obtain a complete 
and accurate description of the steric interaction between a complex 
substituent and a macromolecular surface. The descriptors named above 
generally apply very well to spherically symmetric substituents. To obtain a 
description of asymmetric substituents. Verloop, Hoogenstraaten, and 
Tipker [29] developed a multiparameter method called Sterimol 
(Figure 1.1) 
Sterimol uses five parameters: Bi, B2, B3, B4, and L. The first four 
parameters are the widths of a substituent measured in four rectangular 
directions. The fifth parameter, L, is the length of the substituent along the 
1 
1 
fP 
—-"-/-- * -J-
\ 1 j L axis y' 
\ B3 B4 
Q 
1 
» -
B2 
B L axis 
Figure 1.1 Selection of Sterimol parameters for a substituent. 
axis of the bond between the first atom of the substituent and the parent 
molecule. For calculating the steric dimensions, Sterimol includes a 
computer program that uses van der Waals radii, standard bond lengths and 
angles, and logical conformations. 
A detailed QSAR study requires five Sterimol parameters to account 
for steric effects. A statistically justified investigation requires fifteen 
congeners to analyze steric factors. A biological activity, however, rarely 
depends on steric factors only, so electronic, hydrophobic, and dispersion 
factors must also be considered. More congeners are required to obtain a 
meaningful QSAR, which is especially true when two or more substituent 
positions are present in the congeneric compound group. To accommodate 
the extra congeners, Verloop [38] reduced the number of parameters to 
three when updating Sterimol. These are L, Blt and B 5 , with L still 
representing the length of the substituent, B1 the smallest width, and B5 
the largest width. B5 is often equal to parameter B4 of the original Sterimol 
[24]. 
1.3.5 Minimum Topological Difference (MTD) Calculations 
Another parameter for describing steric substituent effects is the 
minimum topological difference (MTD). Simon et al. [39] defined the 
minimum steric difference (MSD) between a compound and the natural 
substrate of a biological system as the non-overlapping volume of the lowest 
energy conformation of the two molecules. In practice, this means that the 
planar structural formulas of the molecules are superimposed and that the 
non-superimposable atoms are counted (Figure 1.2). One method of 
estimating the deviation from the ideal bulk as represented by the natural 
substrate is to characterize the MSD parameters. There are, however, 
certain problems inherent in this method. These are: 
- The subjectivity in superimposing the molecules; 
- The difficulty of defining the natural substrate, which is often 
unknown in QSAR studies. Simon et al. adopted the most active 
molecule of a congeneric group as the standard, assuming that its 
shape would be most like that of the "natural" substrate; 
- The lack of discrimination between differences in the shape of the 
molecule directed towards the binding site of the receptor (which 
would be relevant) and differences in the shape towards other 
directions (which would be irrelevant). 
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"Natural" Substrate 
HO H 
Without Hydrogens 
O 
HO—? y—ci 
H H 
CH2-NH2 
CH2 o-J V c 
C—N 
MSD = 0 
/ \ 
C—N 
o-^n 
C—N 
* : missing 
MSD = 1 
+ : extra 
MSD = 1 
V w 
C—N 
v X-c. 
C—N 
MSD = 2 MSD = 3 
Figure 1.2 Calculation of the MSD parameters (Reference 40). 
Recently, Balaban et al. [31] described a method tha t overcomes these 
problems to a certain extent. Called the minimum topological difference 
(MTD) method, it is based on the development of an optimal s t anda rd 
molecule by sys temat ic analysis of the s h a p e s of the m e m b e r s of a 
congeneric group in relation to their biological activities. The method 
consists of the following steps: 
- Develop a so-called "hypermolecule" (i.e. a molecule t h a t is the 
assemblage of all atomic positions of all molecules in the congeneric 
group). Figures 1.3 and 1.4 i l lustrate th is for some subs t i t u t ed 
benzonitri les; 
- Choose an initial s tandard molecule (e.g. the most active member) and 
calculate the MTD values of all the members using the MSD method. All 
the positions in the hypermolecule will now change, one by one, until 
they have been accounted for, favorable, unfavorable, and indifferent 
(i.e. not adding to the MTD value at all). After each change, correlate 
the MTD values with the biological activity and optimize the correlation 
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coefficient using the steepest ascent method. If no single change in the 
final standard can produce MTD values that correlate better with the 
biological activity, derive an optimum standard; 
Repeat the first two steps several times, starting from different initial 
standards (e.g. the entire hypermolecule or initial standards that have 
been randomly generated) until most optimizations have led to the 
same standard. This will avoid the results indicating only a local 
optimum of the standard. 
Compound 
H3Cv 
*cr ^ r "o' 
ON 
.CH, 
CI 
cf 
CN 
r^ r 
CN 
^CF3 
^ 0 V c , C H 3 
-c° 
H2cr 
CH, 
CH; 
CN 
CI 
Hypermolecule 
Figure 1.3 Construction of the hypermolecule of some substituted 
benzonitriles (Reference 40). 
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Balaban et al. accounted for the additional influence of electronic, 
hydrophobic, and dispersion effects by adding a, JC, and MR to the 
regression after developing an optimum standard. In contrast, Tipker and 
Verloop [40] preferred to add those parameters sooner, while developing 
the optimum standard. They called the resulting values MTD* parameters. 
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l 
7 \ 
/ 
CN 6 
2 \ 
/ 1 1 
10 
I 
-4 
All of the compounds can be covered by 
hypermolecule. None of the positions is superfluous. 
the 
Compound 
H 
2-CI 
2,6-F2; 2,6-CI2; 2,6-
2-F.6-CI; 2-CI.6-OH 
2-CI,6-Br; 2-CI,6-Ch 
3-CI 
2-OCH3 
2-CF3,6-CI 
2-OC2H5,6-CI 
2,6-(OCH3)2 
2,6-CI2,3-OCH3 
2,6-CI2,3-OCOCH3 
2,3,6-CI3 
2,3,5,6-CI4 
2,5-(OC2H5)2 
Br?; 
2,6 
3 
2,6-l2 
-(CH3)2 
Positions 
1 
1 2 
1 2 3 
1 2 3 
1 2 3 
1 8 
1 2 4 
1 2 3 4 5 6 
1 2 3 4 10 
1 2 3 4 7 
1 2 3 8 10 
1 2 3 4 8 1 0 11 
1 2 3 8 
1 2 3 8 9 
1 2 4 7 , 9 10 12 
Figure 1.4 Atomic positions in the hypermolecule of some substituted 
benzonitriles (Reference 40). 
1.4 REGRESSION ANALYSIS 
Multiple regression analysis is statistical calculation based on the 
method of least squares. It is best done with a computer. The validity of the 
equations and the relative importance of the different parameters are 
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judged by statistical criteria. These are the multiple correlation coefficient 
(r2), the F value, the t value, and the standard deviation (s). A brief 
description of the criteria follows. For more information, refer to the 
literature [41]. 
The multiple correlation coefficient (r2) is the degree of 
correspondence between the biological data that were obtained in 
experiments and those that were calculated by regression analysis, where 
r 2 = 1.0 is a perfect fit. This coefficient, which is often used without the 
other criteria, is, in fact, the least reliable estimate of "goodness of fit". Its 
value is that fraction of the sum of the squares of the deviations of observed 
responses from mean responses (in other words, the Variance in the data) 
that is attributable to the regression equation. 
The F value is the decision statistic of the F test of significance. It 
indicates whether the correlation of the equation found is significant. When 
n = number of data and k = number of independent variables, the F value 
must be checked in a table of distribution values under k and n - k - 1 
degrees of freedom [42]. If the F value from the regression equation is 
greater than the critical F value in the table, the correlation is significant. 
The t value of the regression coefficients a, b, c, d, and e (Equation 
1.1) is a measure of how much the corresponding parameters add to the 
correlation. A specific parameter adds significantly to the correlation only 
when the t value of the corresponding parameter is greater than the critical 
t value associated with n - k - 1 degrees of freedom; confidence intervals of 
90 or 95 % can be calculated instead of t values. 
The standard deviation (s) indicates how closely the biological data 
obtained in experiments correspond with those calculated by regression 
analysis. 
As a rule, a stepwise method is best in regression analysis. Such a 
method allows one to add the parameters while observing the change in the 
statistical criteria. Moreover, as it is important to check for intercorrela-
tions between supposedly independent variables, a matrix of the coefficients 
of all possible intercorrelations will have to be made. Intercorrelated 
parameters are permissible only if a significant decrease in the standard 
deviation has been obtained. Despite this, checks for possible inter-
correlations are not always done in QSAR studies. 
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1.5 EXAMPLES 
Numerous QSAR studies have focused on the inhibition of certain 
enzymes. Two of these enzymes are of interest here, namely xanthine 
oxidase and dihydrofolate reductase. A more detailed treatment of xanthine 
oxidase follows in the remaining chapters of this thesis. 
1.5.1 Xanthine Oxidase 
Xanthine oxidase converts hypoxanthine (1.1a) to xanthine (1.2) and 
then to uric acid (1.3a). A high production of uric acid leads to a high 
concentration of sodium urate in the extracellular fluids. Because of its 
relative insolubility, sodium urate builds up in subcutaneous sites such as 
joints, ultimately causing gout. 
1.1 1.2 
a:X = 0 a:X = 0 
b:X = S b:X = S 
Xanthine oxidase also converts 6-mercaptopurine (1.1b), an 
antileukemic drug, to thiouric acid (1.3b). The selective action of 
6-mercaptopurine on tumor cells has been linked to the absence or low 
concentration of xanthine oxidase in those cells. Accordingly, one can 
assume that tumor cell lines, which are unresponsive to 6-mercaptopurine, 
contain high levels of xanthine oxidase and that selective inhibition of 
xanthine oxidase is useful in 6-mercaptopurine therapy. 
Baker and co-workers [43] synthesized an extensive series of xanthine 
oxidase inhibitors and measured the biological activity. Silipo and Hansch 
[44] compiled Baker's data and made a QSAR study of derivatives of 
9-(R-phenyl)guanines (1.4-1.69, Table 1.2). 
The QSAR study by Silipo and Hansch revealed a correlation between 
the inhibitory activity of the compounds, the molar refractivity, and the Taft 
steric parameters: 
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Table 1.2 Inhibitors of Xanthine Oxidase and Their Inhibition Activity 
..À:> 
•4^R 
Compou 
1.4 
1.5 
1.6 
1 .7 
1.8 
1.9 
1.10 
1.1 1 
1.12 
1.13 
1.14 
1.15 
1.16 
1.17 
1.18 
1.19 
1.20 
1.21 
1.22 
1.23 
1.24 
1.25 
1.26 
1.27 
1.28 
1.29 
1.30 
1.31 
1.32 
1.33 
1.34 
1.35 
1.36 
nd Ra> 
2-CI 
2-Br 
3-X-3'-S02F, 4-OCH3 
3-Y-3'-S02F, 4-OCH3 
3-X-4'-S02F, 4-OCH3 
2,3-CH=CHCH=CH 
3-Y-4'-S02F, 4-OCH3 
4-Z-4'-S02F 
4-NH(CH3)2 
4-NHCOCH2Br 
4-CI 
4-C(CH3)3 
4-CH3 
4-CF3 
3,4-CI2 
4-0(CH2)3X-4'-S02F 
4-Z-3'-S02F 
3,4-(OCH3)2 
4-Y-4'-S02F 
4-0(CH2)2Y-4'-S02F 
4-0(CH2)3X-4'-S02F 
4-C2H5 
4-0(CH2)3Y-3'-S02F 
2-F 
4-(CH2)3CH3 
3-NH2 
4-0(CH2)2Y-3,-S02F 
4-OCH3 
4-0(CH2)2Y'-4'-CH3, 3' 
4-CONH2 
3,4-CH=CHCH=CH 
H 
4-0(CH2)3X-3'-S02F 
-Log l50b) 
5.09 
5.11 
5.25 
5.31 
5.35 
5.38 
5.39 
5.60 
5.68 
5.72 
5.74 
5.74 
5.80 
5.89 
5.96 
6.00 
6.02 
6.14 
6.15 
6.16 
6.16 
6.17 
6.20 
6.21 
6.21 
6.22 
6.28 
6.30 
-S02F 6.31 
6.38 
6.39 
6.39 
6.40 
Compou 
1.37 
1.38 
1.39 
1.40 
1.41 
1.42 
1.43 
1.44 
1.45 
1 .46 
1.47 
1.48 
1.49 
1.50 
1 .51 
1 .52 
1.53 
1.54 
1.55 
1.56 
1.57 
1 .58 
1.59 
1.60 
1.61 
1.62 
1.64 
1 .65 
1.66 
1.67 
1.68 
1.69 
nd Ra) 
4-0(CH2)2X-4,-S02F 
4-Y-3'-S02F 
3-CI 
CH(CH3)2 
4-C6H5 
3-CH3 
3-NHCHO 
3-4-OCH3 
4-OH 
4-0(CH2)2X-3'-S02F 
3-CF3 
4-0(CH2)2X'-4'-CH3, 3' 
3-Y-3'-S02F 
4-OC2H5 
-Log l50b> 
S02F 
3-NHCOCH2OC6H4-4'S02F 
4-0(CH2)2X'-2'-CI, 5'-S02F 
3-Y'-4'-CH3, 3-S02F 
4-0(CH2)3C6H5 
3-C6H5 
3-NHCOC6H5 
3-NHCOCH2Br 
3-Y'-2'-CI, 5'-S02F 
4-0{CH2)2-X,-2,-OCH3,5'-S02F 
3-X'-2'-CI, 5'-S02F 
3-Y-4'-S02F 
3-X'-3'-CI, 4'-S02F 
4-NHCO(CH2)2C6H4-4 
3-X-4'-S02F 
3-X'-4'-CH3, 3"-S02F 
3-X'-2'-OCH3, 5'-S02F 
-S02F 
3-NHCOCH2C6H4-4'-S02F 
3-NHCO(CH2)4C6H4-4 -S02F 
6.48 
6.55 
6.57 
6.60 
6.60 
6.62 
6.64 
6.66 
6.68 
6.74 
6.82 
6.92 
6.96 
6.96 
7.00 
7.04 
7.04 
7.08 
7.09 
7.14 
7.15 
7.15 
7.16 
7.28 
7.29 
7.48 
7.58 
7.62 
7.74 
7.80 
7.82 
8.00 
a) X = NHCONHC6H4, Y = NHCOC6H4, Z = NHS02C6H4, X' 
b) -Log l 5 0 values were taken from Reference 42. 
NHCONHC6H3, Y' = NHCOC6H3. 
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log 1/I50 = 0.267(±0.06)MR3 - 0 . 6 4 7 ( ± 0 . 1 2 ) { M R 3 * M R 4 } + 
1.291(±0.39)ES2 + 0.101(±0.04)MR4 + 
0.252(±0.11)ES4 + 4.552(±0.45) (1.6a) 
n = 65 r = 0.910 s = 0.308 
The superscript of the parameters shows the position of the 
substituent (R). The positive coefficient of MR3 indicates a positive 
interaction for bulky substituents at position 3. The negative coefficient of 
the cross-product term, M R 3 * M R 4 , shows that bulky substituents at 
positions 3 and 4 substantially reduce the inhibitory activity, suggesting 
that the substituent space near these positions is limited. This is caused 
primarily by the substituent at position 4. The coefficient of MR4 is small 
and the positive coefficient of E s 4 indicates a steric hindrance at that 
position (the bulkier the substituent, the more negative the value of Eg). 
Moreover, the high coefficient for E g 2 indicates a strong steric 
hindrance at position 2. 
Recently, Folkers [45] used computer-aided molecular graphics to 
model the interaction of some derivatives of 7-phenylpyrolo-
[2,3-d]pyrimidine with some model receptors of the active site in 
xanthine oxidase. His results were disappointing and further research is 
needed. 
1.5.2 Dihydrofolate Reductase 
Dihydrofolate reductase (DHFR) catalyzes the reduction of 
dihydrofolate to tetrahydrofolate, a substance only one step short of the 
coenzyme for thymine synthesis. The design of DHFR inhibitors is an 
important goal of research on antibacterial and antitumor drugs. A recent 
exhaustive review of the QSAR of DHFR inhibitors [46] showed that a 
wide variety of compounds had been tested and that, consequently, an 
equal number of QSAR's had been generated. Depending on the source of 
the enzyme and the type of the inhibitor, several parameters (steric, 
electronic, and hydrophobic) had produced a relevant correlation, but 
hydrophobic parameters were dominant. 
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Table 1.3 Inhibitors of Chicken Liver Dihydrofolate Reductase and Their 
Inhibition Activity 
Compound 
1.70 
1.71 
1.72 
1.73 
1.74 
1.75 
1.76 
1.77 
1.78 
1.79 
1.80 
1.81 
1.82 
1.83 
1.84 
1.85 
1.86 
1.87 
1.88 
1.89 
1.90 
1.91 
1.92 
1.93 
1.94 
1.95 
1.96 
NH2 
H 2 i s r ^ N 
R 
3,4,5-(CH2CH3)3 
3,5-(OCH3)2, 4-(OCH2CH2OCH3) 
3,4,5-(OCH3)3 
3,5-(OCH3)2, 4-N(CH3)2 
3,5-(OCH3)2, 4-Br 
3,5-(OCH3)2, 4-SCH3 
3,5-(OCH3)2, 4-C(CH3)=CH2 
3,5-(OCH2CH3)2, 4-C4H4N 
3,5-(CH2OH)2 
3,5-(OCH3)2 
3,5-(OCH2CH3)2 
3,5-(CH3)2 
3,4-(OH)2 
3-N02, 4-NHCOCH3 
3,4-(OCH2CH2OCH3)2 
3,4-OCH20-
3,4-(OCH3)2 
3-CF3, 4-OCH3 
3-0(CH2)7CH3, 4-OCH3 
3-OCH2CONH2 
3-CH2OH 
3-OS02CH3 
3-CH2OCH3 
3-OH 
3-OCH2CH2OCH3 
3-OCH3 
3-F 
jTC HK 3R 
-Log K|a) Compound R 
5.25 1 
3.64 1 
3.98 1 
4.15 1 
4.54 1 
4.29 1 
4.17 1 
4.33 1 
3.23 1 
4.12 1 
4.14 1 
4.16 1 
3.59 1 
4.34 1 
3.91 1 
4.68 1 
4.46 1 
4.99 1 
4.71 1 
4.27 1 
4.31 1 
4.33 1 
4.37 1 
3.87 1 
4.83 1 
4.45 1 
4.70 
97 
98 
99 
100 
101 
102 
103 
104 
105 
106 
107 
108 
109 
110 
1 11 
1 12 
113 
1 14 
115 
1 16 
1 17 
118 
119 
120 
121 
122 
3-CH3 
3-CI 
3-Br 
3-CF3 
3-CH20(CH2)3CH3 
3-I 
3-0(CH2)3CH3 
3-OCH2C6H5 
3-0(CH2)5CH3 
3-0(CH2)6CH3 
3-0(CH2)7CH3 
4-NH2 
4-NHCOCH3 
4-OCH2CH2OCH3 
4-N02 
4-OCH3 
4-F 
4-CH3 
4-CI 
4-Br 
4-OCH3 
4-0(CH2)3CH3 
4-OCH2C6H5 
4-0(CH2)5CH3 
4-0(CH2)6CH3 
H 
-Log Kja> 
4.72 
5.01 
5.03 
4.92 
5.17 
4.79 
5.22 
5.63 
5.67 
4.79 
5.08 
3.73 
4.26 
4.26 
4.37 
4.29 
4.79 
4.56 
4.83 
4.79 
4.32 
4.67 
4.83 
4.71 
4.73 
4.71 
a) -Log Kj values were taken from Reference 45. 
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Fortunately, the X-ray s t ruc ture of DHFR is known, which made it 
poss ible for Selass ie et al . [47] to corre la te a QSAR of severa l 
benzylpyrimidine analogues (1 .70-1.122, Table 1.3) with molecular-graphics 
m o d e l s c o n s t r u c t e d from X-ray c r y s t a l l o g r a p h i c c o o r d i n a t e s of 
t r ime thopr im ( 1 .72 ) a n d 5 - (3 ,5 -d imethoxy ,4 - i sopropeny lbenzy l ) -2 ,4 -
diamino-pyrimidine (1.76) bound to DHFR (Table 1.3). This QSAR indicates 
tha t bulky subst i tuents have a favorable effect at position 3, as shown below 
by the positive coefficient for MR«* and K&: 
Log 1/Ki = 0.43(±0.11) TC3- 1.13(±0.35(logU33*10*3 + 1) 
- 0 . 6 6 ( ± 0 . 1 9 ) M R 5 + 0.59(±0.22)7r4 + 0.48(±0.30)7t5 
- 0.63(±0.33)logÜ34*10*4 + 1) + 
0.14(±0.09)MR3 + 4.64(±0.14) (1.6b) 
n = 53 r = 0.921 s = 0.208 F = 8.07 
l o g ß 3 = - 2 . 2 1 logJ3 4 = -0.07 
For the meta - subs t i tu ted compounds, a single subs t i tuent is called 3 . 
When two subs t i tuen ts are present, they are called 3 and 5. At position 5, 
there seems to be a strong steric h indrance to binding, which offsets the 
smaller positive hydrophobic effect indicated by rfi. T h u s the binding at 
position 5 seems to occur in a sterically limited hydrophobic space. At 
positions 3 and 4, the subst i tuents seem to have an optimum hydrophobicity 
value. 
After calculating Equat ion 1.6b, Selassie et al. viewed the possible 
interactions of the inhibitors with DHFR using molecular graphics based on 
X-ray crys ta l lographic da ta of DHFR and molecular models of the 
compounds. The agreement was remarkable. At position 4, for example, it 
appears that, in the aqueous phase, subst i tuents larger than 4-n-butoxy will 
meet a polar area and eventually pro t rude beyond the enzyme space . 
Similarly, a long hydrophobic subst i tuent at position 3 can bind very well up 
to a value of n = 2.00. Beyond this point, steric h indrance occurs owing to 
blockage of the subst i tuent by a proline residue from the enzyme. 
Selassie et al. show very clearly how QSAR (which indicates possible 
interactions and at which positions) and molecular graphics (which give a 
more detailed picture of the interactions) can complement each other. 
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1.6 OUTLINE OF THIS THESIS 
Xanthine oxidase is one of the first enzymes for which a highly 
purified preparation was obtained [48]. Because it is easy to isolate, well-
documented, and commercially available, it has become a common subject 
of research for biochemists and medicinal chemists. 
The goal of this thesis is to shed more light on the structural 
requirements for binding organic compounds with xanthine oxidase. 
Chapter 2 contains a description of the synthesis of the organic 
compounds used for this thesis. 
Chapters 3 and 5 contain the results of inhibition studies of two 
different congeneric compound groups and a discussion of a structure-
activity relationship for both. 
Chapter 4 contains a discussion of the oxidation of hypoxanthine 
analogues by xanthine oxidase. 
Chapter 6 contains general results and a general discussion of the 
structure of the active site. The results and the discussion are based on 
research that was done for this thesis and on previous work of this 
University's Department of Organic Chemistry. 
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SYNTHESIS OF THE STARTING COMPOUNDS 
2.1 INTRODUCTION 
Tramper et al. [1] have established that immobilized xanthine oxidase 
is an effective reagent for oxidizing the pteridin-4-ones (2.1a) and their 7-
alkyl (2.1b) and 7-aryl (2.1c) derivatives into the corresponding lumazines 
(2.2). The 7-arylpteridin-4-ones (2.1c) are especially good substrates. Their 
Km value is lower than that of xanthine (2.3a), the pteridin-4-ones, and the 
alkylpteridin-4-ones, indicating that the 7-aryl compounds are bound more 
strongly to the enzyme [lb]. This is probably due to an interaction of the aryl 
group with a hydrophobic region at the active site of xanthine oxidase. 
Researchers have observed such an interaction with 9-arylpurines [2], 3-
aryl-5,7-dihydroxypyrazolo[l,5-a]pyrimidines [3a], and 2-aryl-4-trifluoro-
methylimidazoles [3b]. 
The 6-phenylpteridin-4-ones behave quite differently. They are very 
poor substrates for xanthine oxidase, effectively inhibiting it in the oxidation 
of xanthine and 7-arylpteridin-4-ones [lb]. 
o 
HN V 
H 
2.2 2 .3 
a:R = H a:R = H 
b: R = Alkyl b: R = Alkyl 
c: R = Aryl c: R = Aryl 
Continuing interest in new, more effective, and more specific 
xanthine oxidase inhibitors [3] has prompted more detailed investigations of 
the inhibitory properties of the 6-arylpteridin-4-ones (2.6) and the 8-
arylhypoxanthines (2.9). A description of some synthetic methods of 
obtaining these compounds follows. 
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There are two syn the t ic m e t h o d s of ob ta in ing 6 - s u b s t i t u t e d 
pteridines, namely the Taylor method [4] and the Gabriël-Isay method [6]. 
The Taylor method is the most recent. De Meester et al. [5] have used it to 
synthesize several 6-arylpteridin-4-ones (Scheme 2.1). 
HC(OC2H5)3 
1.Na2S2Q4 H N ^ Y ' 
2. KMn04 l ^ JJ^ 
Scheme 2.1 
The Taylor method is very elegant, for the pteridines obtained with it 
are not contaminated by isomeric subs t i tu ted pter idines , as are those 
obtained with the Gabriël-Isay method. Nevertheless, the Taylor method 
involves four reaction steps, and its final yield is relatively low. Moreover, 
using this method, De Meester et al. [5b] were able to synthesize 2 . 6 with 
only five different aryl groups. 
A more general way to obtain pteridines is with the Gabriël-Isay 
method, in which a 4,5-diaminopyrimydine reacts with a 1,2-dicarbonyl 
compound (Scheme 2.2). 
H N A ^ N H 2 
% ^ N H 2 
2 .4 
Ethanol
 HN. 
Reflux 
Scheme 2.2 
2 .6 
+ 7-phenyl isomer (2.1c) 
25 
For pteridin-4-ones, when an aryl group substitutes for the hydrogen 
at position 6, this reaction requires 4,5-diaminopyrimydin-6-one (2.4) and 
an arylglyoxal (2.5). The reaction, however, usually produces a mixture of 6-
aryl and 7-aryl substituted pteridin-4-ones [7]. The acidity of the reaction 
medium influences the ratio of the two products, so that the 7-arylpteridin-
4-ones (2.1c) thus obtained are almost pure when the reaction is done at pH 
7.5. The 6-arylpteridin-4-ones (2.6) are obtained with a more acidic 
medium [7a-b]. 
For this thesis, the Gabriël-Isay method was preferable, as it involves 
only one step, and the problem of separating the isomeric 6-arylpteridin-4-
ones and 7-arylpteridin-4-ones was solved in the course of the research. 
The 8-arylhypoxanthines (2.9) were synthesized with starting 
compounds similar to those that were used to synthesize the pteridines. 
These synthetic procedures are outlined in Scheme 2.3. The first series of 
8-arylhypoxanthines was synthesized according to a method developed by 
Garmaise and Komlossy [8] (method A). Later series were synthesized 
according to a method proposed by Fu et al. [9] (method B), which extends 
the congeneric series. 
NH-, HO 
HN' 
^NT ^ N H 2 
2.8 
Method A 
2 .7 
Method B 
2 .11 
Scheme 2.3 
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2.2 MATERIALS AND METHODS 
2.2.1 Materials 
The para-substituted benzoic acids and several of the para -subs t i tu ted 
acetophenones used for the research presented in this thesis were bought 
from Aldrich. The acetophenone derivatives with X = iodo, ethyl, n-propyl, 
i-propyl, i-butyl, and n-butyl were easily synthesized with a Friedel-Crafts 
acetyla t ion of the appropr ia te benzene derivat ives. The s u b s t i t u t e d 
phenylglyoxals were obtained with publ i shed p rocedures [10]. Melting 
points were measured on a Kofier hot plate . They are presented here 
uncorrected . 
The *H-NMR spectra were recorded in deuterated dimethylsulfoxide 
(DMSO-dö) on either a Hitachi Perkin-Elmer R24B spectrometer, a Varian 
EM-390 spectrometer, or a Bruker CXP-300 spectrometer operating in the 
Fourier transform mode, with tetramethylsi lane as an internal s t anda rd 
(5 = 0 ppm). The 1 3C-NMR spect ra were recorded in the same solution 
(DMSO-d6) on either a Varian XL-100 spectrometer or a Bruker CXP-300 
spectrometer operating in the Fourier transform mode and employing the 
solvent peak as a s tandard (5 = 39.6 ppm). 
2.2.2 Synthesis of the 6-(pX-Phenyl)Pteridin-4-Ones(2.6a-m) 
A solution of 3.5 g (22.7 mmole) of 4,5-diaminopyrimidin-6-one (2.4) 
in 50 ml of 96% ethanol was acidified with diluted sulphuric acid to pH 2.7 
at 60°C. Subsequently, 27 mmole of compound (2.5), dissolved in 20 ml of 
96% ethanol, was stirred into the solution. This reaction mixture was then 
refluxed. The pH was kept at 2.7 with the addition of 0.5 N NaOH. When the 
pH had remained constant for approximately two hours , the mixture was 
allowed to cool. 
The crystals obtained from the react ion were then filtrated and 
washed with ethanol and ether. The crude product (yield 70 to 90%), which 
conta ined both the 6-aryl and 7-aryl i somers of p ter id in-4-one , was 
fractionated by recrystallization from DMSO. The 7-isomer crystallized first. 
Finally, an equal volume of water was added to the filtrate to precipitate the 
6-isomer and residual 7-isomer. This procedure was repeated until the 6-
isomer was free from any 7-isomer, as judged by !H-NMR. 
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An alternative recrystallization method was possible for compounds 
2.6g-j (Table 2.1). In this method, the crude p roduc t of the react ion 
mixture was washed extensively with hot methanol . The residue was the 
7-aryl isomer. The methanol filtrates were then combined, concentrated by 
vacuum-evapora t ion , and cooled unt i l they crystallized. This fraction 
contained mainly the 6-isomer. Recrystallization from methanol yielded the 
pure compounds, as judged by iH-NMR. 
2.2.3 Synthesis of the 8-(pX-Phenyl)Hypoxanthines(2.9a-k) 
With Method A [9] 
Equal molar amounts (30 mmole) of 4,5-diaminopyrimidin-6-one and 
the appropr ia te benzoic acid were mixed in 30 ml of freshly prepared 
polyphosphoric acid. The reaction mixture was heated to 190°C, st irred 
continuously at tha t temperature for two hours , and allowed to cool. The 
resul t ing dark-brown solut ion was diluted with 200 ml of water and 
filtrated. 
The filtrate was then neutralized with a solution of 2 5 % NaOH and the 
resulting precipitate was filtrated. The crude product was dissolved in 1 N 
NaOH, norit was added, and the solution was refluxed for ten minutes . The 
hot solution was filtrated and the filtrate was acidified with acetic acid. 
The filtrate was then cooled to 4°C and the resulting precipitate was 
collected by filtration. The crude product was purified by an additional base-
acid precipitation and washed with alcohol and ether. The final product was 
dried in vacuo with phosphorus pentoxide. 
With Method B [10] 
To prepare the subst i tuted benzoyl chloride, 15 g of the appropriately 
subst i tu ted benzoic acid were dissolved in 100 ml of SOCl2. The resulting 
mixture was refluxed for one hour and the excess SOCl2 was evaporated in 
vacuo. The remaining liquid was used for the next s tep wi thout being 
purified further. 
The benzoyl chloride was then cooled to 0°C and mixed with 10 g of 
4,5-diaminopyrimidin-6-one tha t had been dissolved in 100 ml of 1 N 
NaOH. The mixture was stirred at 0°C for forty-eight hours . The result ing 
turbid solution was made more alkaline with the addition of some solid 
NaOH. The solution was extracted with ether, whereupon the aqueous layer 
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became clear. This basic solution was acidified to pH 5 with 6 N HCl. The 
resulting precipitate was collected by filtration and washed with water and 
ether. 
The 4-amino-5-arylamidopyrimidin-6-one (2.11) was then purified. 
This was done by dissolving it in 0.5 N NaOH and refluxing it with norit for 
ten minutes. The norit was filtered off and the filtrate was acidified to pH 6 
with 4 N HCl. The resulting precipitate was filtered, washed with water and 
ether, and dried in vacuo with phosphorus pentoxide. 
The ring closure of 4-amino-5-arylamidopyrimidin-6-one (2.11) was 
then accomplished. This was done by mixing in a flask 15 mmole of the 
compound with 25 g of phosphorus pentoxide. The flask was cooled in ice 
and 18 ml of 85% polyphosphoric acid were added. The reaction mixture 
was heated to 180°C and kept at that temperature for four hours, after 
which the hot solution was poured over crushed ice. This solution was 
neutralized to pH 5 with 6 N NaOH and the resulting precipitate was 
filtered off. 
The crude product was then dissolved in 1 N NaOH and refluxed with 
norit for ten minutes. The norit was removed and the filtrate was acidified 
to pH 6. The resulting precipitate was collected by filtration, washed with 
water and ether, and dried in vacuo with phosphorus pentoxide. 
2.3 RESULTS AND DISCUSSION 
2.3.1 Synthesis of the 6-Arylpteridin-4-Ones 
The 6-arylpteridin-4-ones (2.6a-m) used for this thesis were 
synthesized by condensing 4,5-diaminopyrimidin-6-one (2.4) with an 
arylglyoxal derivative (2.5) according to published procedure [7a]. The 
results are shown in Table 2.1. The product is usually a mixture of 6-
arylpteridin-4-one and the 7-substituted isomer (2.1c). Nevertheless, the 
composition of the reaction mixture depends on the pH at which the 
reaction is carried out. At pH 2.7, the main product is 2.6 (Table 2.2). 
To obtain pure 2.6, the reaction products were recrystallized from 
dimethylsulfoxide (DMSO) or from methanol, as described in the section on 
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Table 2.1 Synthesis of the 6-Arylpteridin-4-Ones 
vhT ^N ' 
No. 
2.6a 
2 .6b 
2.6c 
2 .6d 
2 .6e 
2.6f 
2.6g 
2 .6h 
2.6i 
2.6j 
2.6k 
2.6I 
2.6m 
Pterid 
X 
H 
F 
Cl 
Br 
I 
Me 
Et 
n-Pr 
/-Pr 
f-Bu 
OCH3 
n-Bu 
OH 
M. Pt. 
(°C) 
304e) 
322e) 
313e) 
315e) 
332e) 
286e) 
253-5 
255-8 
233e) 
265e> 
280e) 
260e) 
340 
ne-4-oned) 
7-Phenyl- 345 
Pteridine-4-one 
Yield 
% 
35% 
6% 
6% 
17% 
22% 
23% 
25% 
25% 
20% 
15% 
15% 
5% 
10% 
75% 
Formula 
Ci2H 8N 4O.H 20 
C12H7N4FO 
c 1 2 H 7 N 4 C I O H 2 ° 
C12H7N4BrO.H20 
C12H7N4IO 
C13H10N4O.H2O 
C14H-12N4O 
C 1 5 H 1 4 N 4 0 
C 1 5 H 1 4 N 4 0 
C 1 6 H 1 6 N 4 0 
C13H10N4O2.H2O 
C 1 6 H 1 6 N 4 0 
C 1 2 H 8 N 4 0 2 
C6H4N40 
C 1 2 H 8 N 4 0 
Analysis3) 
C,H 
C,H 
C,H 
C,H 
C,H 
C,H 
C,H 
C,H 
C,H 
C,H 
C,H 
C,H 
C,Hf) 
C,H 
1H-NMRb) 
H-2 
8.35 
8.35 
8.30 
8.30 
8.35 
8.30 
8.30 
8.30 
8.30 
8.33 
8.30 
8.33 
8.30 
8.30 
H-7 
9.58 
9.60 
9.55 
9.55 
9.60 
9.50 
9.56 
9.55 
9.52 
9.53 
9.55 
9.60 
9.50 
9.409) 
13C-NMRC) 
C-6 
149.9 
149.4 
149.4 
149.1 
149.2 
149.5 
150.3 
149.4 
150.3 
150.2 
149.1 
150.6 
149.3 
144.2 
141.9 
C-7 
146.7 
147.5 
147.8 
147.5 
147.2 
146.2 
147.5 
147.3 
147.4 
147.4 
145.9 
147.3 
146.8 
150.2 
155.7 
a) Micro-analyses for C and H were within 0.4% of the calculated theoretical value. 
b) Chemical shifts in .8 (ppm). 
c) Chemical shifts in ppm. 
d) A. Nagel, unpublished results. 
e) Decomposes upon melting. 
f) Analytical calculation for Ci 2H8N402.1/2H20: C, 57.83; H, 3.64; Found: C, 58.48; H, 3.33. 
g) Chemical shift for H-6. 
Table 2.2 Effect of pH on Isomer Formation in 
the Reaction of 2.4 and 2.5 
pH 
7.5 
4.5 
3.5 
2.7 
2.0 
6-lsomer 
2.6a 
<5% 
70% 
70% 
75% 
60% 
7-lsomer 
2.1c 
>95% 
30% 
30% 
25% 
40% 
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materials and methods. The purity of 2.6 was established by *H-NMR 
spectroscopy, which revealed the absence of the H-6 absorbance at 
5 = 9.4 ppm of the 7-arylpteridin-4-one. With the Varian EM-390 
spectrometer, it was possible to detect impurities as slight as 5% in the 6-
arylpteridin-4-one samples. 
Both iH-NMR and 13C-NMR spectroscopy provided solid evidence that 
the aryl group is indeed in position 6. The structure assignment given in 
this thesis is based mainly on 13C-NMR spectroscopy. 
While the aryl group shifts the absorption of the carbon atom to which 
it is attached 5 to 6 ppm downfield, it shifts its neighboring carbon atom 4 
to 5 ppm upfield [11]. Consequently, relative to the C-6 and C-7 signals of 
pteridin-4-one, the separation between the corresponding 13C-NMR signals 
in the 6-arylpteridin-4-ones (3 to 4 ppm) is much smaller than the 
separation between the signals in the 7-phenylpteridin-4-one (13 to 14 
ppm). 
Thirteen 6-arylpteridin-4-ones were synthesized for this thesis with 
the Gabriël-Isay method. In these syntheses, the method showed one minor 
disadvantage, namely the occasional presence in the final product of minute 
amounts of the isomeric 7-arylpteridin-4-ones. One way to avoid this is to 
synthesize the 6-arylpteridin-4-ones from the corresponding pyrazine 
derivatives. The key intermediate in this synthesis is then 2-amino-3-
benzyloxycarbonyl-5-arylpyrazine-l-oxide, as De Meester et al. [5b] showed 
(Scheme 2.1). Although they were able to synthesize many different 2-
amino-3-benzyloxycarbonyl-5-arylpyrazine-l-oxides. De Meester et al. were 
not able to effect subsequent closure of the pyrimidine ring. 
2.3.2 Synthesis of the 8-Arylhypoxanthines 
The 8-arylhypoxanthines used for this thesis were synthesized with 
either method A or method B (Table 2.3). With method A, an initial series of 
seven compounds was synthesized(2.9a and b, and g-k). Fortunately, when 
no more compounds could be obtained with method A, it was still possible 
to synthesize four more compounds (29c-f) with method B. 
With method B, the 4,5-diaminopyrimidin-6-one (2.7) reacted first 
with a pa ra - subs t i tu ted benzoylchloride (2.9) to form 4-amino-5-
arylamidopyrimidin-6-one (2.11). The ring closure of 2.11 to purine (2.9) 
31 
Table 2.3 Synthesis of the 8-Arylhypoxanthines 
No. 
2.9a 
2 .9b 
2.9c 
2 .9d 
2 .9e 
2.9f 
2.9g 
2 .9h 
2.9i 
2.9j 
2.9k 
X 
H 
CH3 
'-C3H7 
n-C4H9 
f-C4H9 
F 
CI 
Br 
N 0 2 
N(CH3)2 
OCH3 
Method3) 
A 
A 
B 
B 
B 
B 
A 
A 
A 
A 
A 
Yield 
% 
60% 
59% 
52% 
54% 
60% 
65% 
62% 
6 1 % 
53% 
48% 
37% 
Analysis 
C,H,N 
C,H,N 
C,H,N 
C,H,N 
C,H,N 
C,H,N 
C,H,N 
M.Pt 
(°C) 
320 b) 
>330 
>330 
>330 
>330 
>330 
>330 
>330 
315 b> 
308 b> 
270 b> 
m/e 
Calc. 
212.0698 
226.0855 
254.1168 
268.1324 
268.1324 
230.0604 
246.0308 
289.9804 
Meas. 
212.0692 
226.0855 
254.1170 
268.1313 
268.1322 
230.0606 
246.0306 
289.9811 
decomposes 
255.1120 
242.0804 
255.1109 
242.0799 
pKac> 
8.6 
8.6 
8.5 
8.9 
7.5 
10.2 
8.8 
a)For details of methods A and B, see Materials and Methods. 
b)Decomposes upon melting. 
c)The pKa values were measured according to Albert and Sergeant [12]. 
was achieved with polyphosphoric acid. Method B was especially suitable for 
synthesizing the alkyl-substituted 8-arylhypoxanthines. 
Attempts to extend this series of 8-arylhypoxanthines with larger alkyl 
or alkoxy groups, or with other subs t i tuen ts such as X = pentyl, ethoxy, 
phenyl, or cyano, were unsuccessful. Although it was relatively easy to form 
4-amino-5-arylamidopyrimidin-6-one (2.11), it was impossible to achieve 
ring closure. To su rmoun t this obstacle, the reaction conditions for closure 
of the imidazole ring were varied. The compounds were refluxed in a 
solution of 30% KOH [13], in acetic acid anhydride [14], in POCl3 [15], in 
absolute ethanol [16], and by sublimation [15]. None of these measu re s 
helped, doubtless because the carbonyl group is somehow deactivated by the 
subst i tuents . Consequently, for this series, the scope of this thesis is limited 
to eleven compounds, namely 2.9a-k. 
The characterization of these compounds was done with ' H - N M R 
spectroscopy, elemental analysis, and molecular weight calculations from 
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the mass spectra. Between 6.8 and 8.1 ppm, the 1H-NMR spectra showed 
the normal AB pa t te rn of the aromatic protons from the aryl group. The 
characterist ic absorption of the H-2 around 8.0 ppm was also evident. As 
might have been expected, measurements showed that , except in the nitro 
and the dimethylamino-substi tuted compounds, the pKa values do not vary 
greatly. 
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QSAR ANALYSIS OF THE INHIBITION OF XANTHINE 
OXIDASE BY 6-ARYLPTERIDIN-4-ONES l) 
3.1 INTRODUCTION 
Xanthine oxidase has three prosthetic groups, namely flavine adenine 
dinucleotide (FAD), molybdenum, and an iron-sulfur cluster. For the most 
part, the mechanism of the electron transfer sequence (from the substrate, 
through the prosthetic groups, towards oxygen) is resolved. The molecular 
weight of xanthine oxidase, however, is high (275,000 to 300,000 daltons), 
making X-ray studies difficult [2], and extended X-ray absorption fine-
structure spectroscopy (EXAFS) studies of the structure of its molybdenum 
centers have only been partially successful [3]. 
Xanthine oxidase is an effective reagent for oxidizing the pteridin-4-
ones and their 7-alkyl and 7-aryl derivatives into the corresponding 
lumazines [4]. The 7-arylpteridin-4-ones are especially good substrates [3b]. 
The 6-arylpteridin-4-ones (3.1) behave quite differently. Contrary to 
their 7-isomeric compound, they are not good substrates for xanthine 
oxidase. Instead, they inhibit the oxidation of xanthine and the 7-aryl-
pteridin-4-ones by xanthine oxidase. It is possible that the strong 
interaction of these arylpteridin-4-ones is due to the interaction of the aryl 
group with a hydrophobic region at the active site of xanthine oxidase [3b]. A 
similar strong interaction has been observed with other aryl-substituted 
inhibitors of xanthine oxidase [5,6]. 
The search for still more xanthine oxidase inhibitors continues. A 
primary goal is to find an alternative to allopurinol (3.2), which is an analog 
of hypoxanthine and the most common potent xanthine oxidase inhibitor 
used to treat gout [7]. Allopurinol has some serious side effects (e.g. 
leukopenia, dermatitis, rashes, renal impairment, and gastro-intestinal 
disorders) [8]. Cessation of treatment generally alleviates these symptoms. 
™'^\ k 
3.2 
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Like all structural analogs of xanthine, allopurinol is a substrate of 
phosphoribosyl transferase, by which it is converted to a ribonucleotide with 
an anti-metabolic potential [9]. Briley and Eisenthal [10a] have reported that 
allopurinol can also be converted to a nucleoside by purine nucleoside 
Phosphorylase. Although it has not been proved, medical researchers 
suspect that prolonged use of these compounds could well be harmful. 
Most inhibitors studied nowadays are related to purines. In their 
QSAR analysis of the 9-aryl-purines, Silipo and Hansch [11] found that 
substituting bulky groups at the ortho or para position in the phenyl ring 
diminishes the inhibitor's effectiveness (Section 1.5.1). A primary goal of 
the research done for this thesis was to evaluate even further the structural 
requirements for binding to the active site of xanthine oxidase. To do this, 
special attention was paid to the effects on inhibitory activity of para-
substitution in the phenyl ring of the 6-arylpteridin-4-ones. In addition, the 
research included testing of the 6-arylpteridin-4-ones with xanthine 
oxidase immobilized on n-octyl-Sepharose 4B (the reaction product of 
CNBr-activated Sepharose 4B and n-octylamine). This was done to 
determine whether an immobilized enzyme system might be a better 
representation of the in vivo situation, where xanthine oxidase is associated 
with membrane systems [10]. 
3.2 MATERIALS AND METHODS 
3.2.1 Materials 
The bovine milk xanthine oxidase (E.C. 1.2.3.2) came from 
Boehringer. The CNBr-activated Sepharose 4B came from Pharmacia. The 
xanthine came from Fluka and the allopurinol came from Aldrich. The 
synthesis of the 6-arylpteridin-4-ones is described in Chapter 2. 
3.2.2 Enzyme Assays 
The xanthine oxidase assay consisted of 2.5 ml of a solution containing 
100 mM sodium phosphate buffer (pH 6.9), 0.1 mM EDTA, 25 to 50 ug of 
xanthine oxidase, 20 to 50 |dM of xanthine, and appropriate amounts of the 
inhibitor. The enzyme assay was done aerobically, at 20°C, at 296 nm 
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(Se = 10.19 mM.cm-l ) , with an Aminco DW2a spectrophotometer set in the 
split-beam mode. The absorption was recorded for two to five minu tes to 
measure the initial oxidation rate. 
A similar assay was then done for xanthine oxidase immobilized on 
n-octyl-Sepharose 4B. The immobilized xanthine oxidase had been prepared 
according to a method described by Tramper et al. [12], with which it was 
possible to immobilize approximately 20 mg of pro te in /g of Sepharose 4B. 
This suspens ion was magnetically stirred in the cuvet while the oxidation 
rate was measured. 
3.3 RESULTS 
3.3.1 Inhibition of Xanthine Oxidase 
The inhibition cons tan t (Kj) was determined for the free xan th ine 
oxidase and Kj' was determined for the immobilized xan th ine oxidase of 
compounds 3 .1a-m (Table 3.1). This was done by measur ing the oxidation 
rate at five different concentrat ions of inhibitor and us ing four different 
concent ra t ions of the xan th ine subs t r a t e . The type of inhibi t ion was 
determined from Lineweaver-Burk plots [13], as Figure 3.1 i l lustrates for 
inhibitor 3.1k. Compound 3 .1k shows a competitive inhibition with the free 
enzyme (Figure 3.1A) and a mixed-type inhibition with the immobilized 
enzyme (Figure 3.IB). 
The same kinetic analysis was done for all the other compounds . 
Table 3.1 summar izes the K; and Kj' values, as determined by Dixon's 
method [14], and the type of inhibition. A similar kinetic analysis of 
allopurinol has been included for comparison. 
The inhibition parameter of all the compounds is of the same order of 
magni tude for both the free and immobilized enzyme. The observed trend 
for the subst i tuent (X) is also similar. Except for compounds 3 . l e and 3.1k, 
the apparen t Kj' value of the immobilized xan th ine oxidase is generally 
higher t h a n the K, value of the free xan th ine oxidase. These da ta are 
insufficient to explain either the difference in the K; values of the two 
enzyme systems or the change in the type of inhibition. 
Compounds 3 .1g and 3 .1h are mixed-type inhibitors, bu t the other 
compounds demonst ra te a competitive inhibition for the free enzyme. All 
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Kinetics of inhibition of xanthine oxidase by 6 - (pOCH3-
phenyl)pteridin-4-one (3.1k). The xanthine oxidase assays were 
performed as described in the section on enzyme assays. In A, 
the free enzyme system (6.8 \ig protein/ml) was used, and the 
inhibitor concentrations were either 5.19 |iM (•-•), 3.11 |j.M (<>-<>), 
1.95 (iM (D-D), 1.04 |aM (B-Q), or none at all (a-a). In B, the 
immobilized enzyme system (18 |o.g protein/ml, 18.4 mg protein/g 
Sepharose) was used, and the inhibitor concentrations were 
either 3.42 ^ M ((•-•) , 2.54 |iM (D-D), 1.83 ^M (o-*), 1.30 ^iM (D-D), 
or none at all (Q-Q). 
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Table 3.1 The K, Values and Type of Inhibition of Various 6-(pX-Phenyl)Pteridin-
4-Ones with Free and Immobilized Xanthine Oxidase 
No. 
3.1a 
3.1b 
3.1c 
3.1d 
3 .1e 
3.1f 
3.1g 
3.1h 
3.1 i 
3.1j 
3.1k 
3.11 
3.1m 
X 
-H 
-F 
-CI 
-Br 
-I 
-methyl 
-ethyl 
-n-propyl 
-/-propyl 
-f-butyl 
-methoxy 
-n-butyl 
-OH 
Allopurinol 
3.1a 
Allopu 
-Hb) 
inolb) 
Free Xanthine 
KJOIM) 
0.17 
0.20 
1.9 
2.5 
3.8 
2.4 
1.1 
0.52 
0.50 
0.45 
1.5 
0.15 
0.30 
7.0 
8.3 
530 
Oxidase 
Type of 
Inhibition3) 
C 
C 
C 
C 
C 
C 
M 
M 
C 
C 
C 
C 
C 
M 
NC 
NC 
Immobilized Xanthine 
Oxidase 
Ki'(uM) 
0.45 
0.55 
2.2 
4.5 
2.25 
3.0 
1.5 
2.4 
2.5 
1.9 
0.85 
1.4 
0.45 
14.0 
11.6 
200 
Type of 
Inhibition3) 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
C 
a)C refers to a competitive inhibition, NC to a noncompetitive inhibiton, and M to a mixed-type 
inhibition [15]. 
b)ln these assays, 7-phenylpteridin-4-one was used as a substrate (8e(315nm) = 4 mM.cm"1). 
the compounds exert a mixed-type inhibition in the immobilized enzyme 
system. 
Comparison of the Kj values of the compounds in Table 3.1 shows that 
the 6-arylpteridin-4-ones inhibit xanthine oxidase much more than 
allopurinol, and that the 6-aryl substituent strongly influences the 
interaction of the compounds with xanthine oxidase. These results support 
previous studies showing that aryl substituents bind the inhibitor more 
tightly to the hydrophobic region of the enzyme's active site [5, 6]. When the 
7-phenylpteridin-4-one is used as the substrate, the same effect occurs and 
the difference between the K; values of 3.1a and those of allopurinol 
becomes even more pronounced. 
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3.3.2 QSAR Analysis 
A QSAR ana lys i s of xan th ine oxidase w a s done to es tab l i sh a 
quantitative relationship between the Ki values and the subs t i tuent present 
in the p a r a posit ion of the phenyl group. With the K{ va lues of the 
compounds tha t were prepared at the s tar t of the program, (3 .1a-k) , the 
QSAR analysis of the free enzyme system produced the following equation: 
-log Ki = -0.795 B x (t = -3.3) + 0.012 (MR)2 (t = 6.0) (3.3) 
- 0.191 MR (t = -5.0) + 1.880 
n = l l r = 0.93 s = 0.21 F = 14.3 
A similar QSAR analysis of the Kj' values of the immobilized enzyme 
system produced a different equation: 
-log Kj' = - 0.465 7C (t = -2.4) + 0.0006 (MR)2 (t = 4.2) (3.7) 
- 0.080 MR (t = -2.6) - 0.360 Bj (t = -2.0) + 0.801 
n = l l r = 0.93 s = 0.15 F = 9.3 
In Equations 3.3 and 3.7, Bl is the minimum van der Waals width, MR 
is t he molar refractivity, and TC is the hydrophobic c o n s t a n t of the 
subst i tuent (X) [16]. The interrelationship of the variables is shown in Table 
3.2. The stepwise development of Equation 3.3 is shown in Table 3.3, and 
that of Equation 3.7 is shown in Table 3.4. 
In the regression analysis, neither the Hammett coefficient, B 5 (the 
maximum van der Waals width), nor L (the van der Waals length) was able to 
Table 3.2 Squared-Correlation Matrix Showing Degree of Colinearity (r2) 
Between the Variables Used 
7t 
B1 
MR 
(MR)2 
K 
1.000 
B1 
0.785 
1.000 
MR 
0.921 
0.785 
1.000 
(MR)2 
0.914 
0.785 
0.985 
1.000 
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Table 3.3 Stepwise Development of a QSAR Analysis for Free Xanthine Oxidase 
Eg. Intercept B1 (MR)2 MR r s F 
3.1 
3.2 
3.3 
0.666 
1.398 
1.880 
-0.363 
-1.014 
-0.795 
0.003 
0.012 
0.35 
0.61 
0.93 
0.45 
0.41 
0.21 
1.3 
2.3 
14.3 -0.191 
Table 3.4 Stepwise Development of a QSAR Analysis for Immobilized Xanthine 
Oxidase 
Eq. 
3.4 
3.5 
3.6 
3.7 
Intercept 
0.040 
0.096 
0.358 
0.801 
7t 
-0.298 
-0.760 
-0.549 
-0.465 
(MR)2 
0.003 
0.006 
0.006 
MR 
-0.085 
-0.080 
Bi 
-0.360 
r 
0.63 
0.77 
0.88 
0.93 
s 
0.26 
0.23 
0.18 
0.15 
F 
6.0 
5.7 
7.8 
9.3 
improve the equations. Bl has a large negative coefficient in both equations, 
which means that an increase in the minimum van der Waals width will 
reduce the effectiveness of the inhibitor. MR h a s an equally negative 
coefficient, bu t it also appears as (MR)2, with a small positive coefficient, so, 
up to a certain value, the increase in the subs t i tuen t ' s size will have a 
negative effect on the inhibitory activity. Nevertheless, if the size of the 
subst i tuent is increased, the MR part of the equation will eventually have a 
positive value. In Equation 3.3, this is reached at MR = 7.96. In Equation 
3.7, it is reached at MR = 6.66. 
The hydrophobicity parameter is necessary to obtain a good analysis 
for Equat ion 3.7. This is quite unders tandab le , a s in the immobilized 
enzyme system, one mus t consider partitioning effects between two phases , 
namely the bulk solution and the Sepharose matrix in which the enzyme is 
immobilized. The hydrophobicity parameter (rc) is derived from an octanol-
water system [16a]. This constant indicates the kind of equilibrium tha t 
exists between the two phases . In this study, it indicates the equilibrium 
between the bulk solution and the Sepharose matrix. In Equation 3.7, n has 
a large negative coefficient, which means t ha t compounds with polar 
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substituents (i.e. with a negative n value) will inhibit immobilized xanthine 
oxidase more effectively than free xanthine oxidase. 
3.4 DISCUSSION 
The results show that several 6-arylpteridin-4-ones are powerful 
inhibitors of the oxidation of xanthine by xanthine oxidase. The Kj value of 
compounds 3.1a and 3.11 is about forty times lower than that of allopurinol. 
If 7-phenylpteridin-4-one is used as a substrate, the Kj value of 3.1a is sixty 
times lower than that of allopurinol. 
The structural similarity of the 6-arylpteridin-4-ones to substrates 
like xanthine and 7-phenylpteridin-4-one, combined with the competitive-
type inhibition that most compounds displayed with free xanthine oxidase, 
strongly suggest that these compounds interact with the active site of the 
enzyme [17]. This would explain the low Kj values obtained for the aryl-
substituted inhibitors. The aryl substituent enhances the binding of the 
compound by interacting with a hydrophobic region in the active site, as 
Baker et al. [5a-c] reported for aryl-substituted purines. 
A QSAR analysis of the 9-arylguanines that Baker et al. synthesized 
showed that a bulky substituent at the ortho and para positions in the aryl 
group reduces the effectiveness of the inhibitor [11]. A QSAR analysis of the 
data in Table 3.1 not only provided a similar result for some of the 
compounds, it also gave a good indication of the shape a substituent needs 
to exhibit good binding properties. 
As mentioned previously, Equations 3.3 and 3.7 show that, while the 
substituent should have some volume, it should not be spherical. A 
comparison of the Kj values of compounds 3. l e and 3.1h demonstrates this. 
The iodo substituent in Table 3.5 is more spherical, as shown by its large 
minimum van der Waals width (B^ The n-propyl substituent, while just as 
"bulky," is more rod-shaped, and thus has a lower Ki value. 
The extra parameter in the QSAR analysis of the immobilized enzyme 
system calls the statistical reliability of the relationship into question, as 
there are four parameters in Equation 3.7 and only eleven compounds to 
explain (Section 1.2). The extra parameter (jt) can be attributed to 
partitioning effects. A reasonable assumption is that a bulky substituent will 
cause a large partitioning effect between the concentrations within the bulk 
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solution and the support. This effect can be diminished to a certain extent 
with a polar substituent, which supports the notion that the Sepharose 
matrix is hydrophilic. Compound 3.1k is a good example of how to diminish 
the partitioning effect, for it has an even lower Kj value for the immobilized 
xanthine oxidase than for the free xanthine oxidase. The other parameters 
are similar to the ones in Equation 3.3 and explain the interaction of the 
compounds with the enzyme. 
This discussion was tested with two new compounds, namely the 
n-butyl-substituted compound 3.11 (which has the same MR values as 3.1j, 
but a much lower B1 value) and the OH-substituted compound 3.1m (which 
has a large negative n value). Table 3.5 shows that the Kj and Kj' values that 
were predicted for both compounds agree with the experimental values. It 
Table 3.5 The Inhibition Constants and Physicochemical Parameters of 
Substituent X of 6-(pX-Phenyl)Pteridin-4-Ones 
SN ^ N ' 
No. 
3.1a 
3.1b 
3.1c 
3.1d 
3 .1e 
3.1 f 
3.1g 
3 .1h 
3.1 r 
3-1 j 
3.1k 
3.11 
3.1m 
X 
-H 
-F 
-CI 
-Br 
-I 
-methyl 
-ethyl 
-n-propyl 
-/-propyl 
-f-butyl 
-methoxy 
-n-butylf) 
-OHf) 
-Log 
Exp.a) 
0.770 
0.699 
-0.279 
-0.398 
-0.580 
-0.380 
-0.041 
0.284 
0.301 
0.347 
-0.176 
0.824 
0.523 
Calcb) 
0.901 
0.641 
-0.283 
-0.459 
-0.259 
-0.039 
0.075 
0.383 
0.081 
0.487 
0.017 
1.361 
0.357 
-LogK 
Exp.3) 
0.347 
0.260 
-0.342 
-0.653 
-0.352 
-0.477 
-0.176 
-0.380 
-0.398 
-0.279 
0.075 
-0.146 
0.347 
Calc.c) 
0.365 
0.182 
-0.436 
-0.527 
-0.417 
-0.262 
-0.393 
-0.293 
-0.421 
-0.265 
0.074 
0.068 
0.449 
B ^ ) 
1.00 
1.35 
1.80 
1.95 
2.15 
1.52 
1.52 
1.52 
1.90 
2.60 
1.35 
1.52 
1.35 
MR8) 
1.03 
0.92 
6.03 
8.88 
13.59 
5.65 
10.30 
14.94 
14.94 
19.62 
7.87 
19.62 
2.85 
7Ce> 
0.00 
0.14 
0.71 
0.86 
1.12 
0.56 
1.02 
1.55 
1.53 
1.98 
-0.02 
2.08 
-0.67 
a) Calculated with the values in Table 3.1. 
b) Calculated withEquation 3.3. 
c) Calculated withEquation 3.7. 
d) Reference 16b. 
e) Reference 16a. 
f) These compounds were not used to develop QSAR Equations 3.3 and 3.7. 
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is especially remarkable that compound 3.11, which has such a large 
substituent, also has such a small Kj value. Nevertheless for a good 
agreement with the calculated value the measured Ki value should be even 
smaller. 
Finally, a QSAR analysis of all the synthesized derivatives was done. 
This produced one last equation for the free enzyme: 
-log Ki = - 0.599 Bi (t = 3.1) + 0.011 (MR)2 (t = 6.2) (3.8) 
- 0.199 MR (t = 5.1) + 1.596 
n = 13 r = 0.93 s = 0.21 F = 18.3 
For the immobilized enzyme, this became: 
-log Kj' = - 0.262 Bx (t = 2.0) - 0.418 n (t = 3.2) + (3.9) 
0.005 (MR)2 (t = 4.5) - 0.076 MR (t = 2.7) + 0.645 
n = 13 r = 0.93 s = 0.14 F = 13.4 
Equations 3.8 and 3.9 are similar to Equations 3.3 and 3.7, except for 
the larger F value. The QSAR analysis showed a decrease in colinearity (from 
0.785 to 0.629 between n and Bj, and from 0.785 to 0.657 between Bi and 
MR), but the new values are still not ideal. Equations 3.8 and 3.9 support 
the results of the previous QSAR analyses. The number of compounds 
increases accordingly from eleven to thirteen, and the number of 
parameters remains the same as that used in Equations 3.3 and 3.7. 
Accordingly for Equation 3.9 there are now at least three compounds for 
every parameter used. 
The results of this QSAR analysis should be interpreted with some 
caution, especially as the range of the log Kj and log Kj' values is not very 
large. Nevertheless, the QSAR analysis has enabled a fairly accurate 
prediction of the inhibition of xanthine oxidase by two other 6-arylpteridin-
4-ones, namely 3.11 and 3.1m. 
The findings presented in this chapter show that the shape of a 
substituent in a compound can have a marked effect on the interaction of 
that compound with an enzyme. This implies that, up to a four-carbon 
substituent at the para position of a 6-arylpteridin-4-one, a rod-shaped 
substituted compound will inhibit xanthine oxidase more effectively than a 
spherical substituted compound. Further studies of other 6-arylpteridin-4-
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ones, especially those substi tuted with acetylamines, which would break the 
still-high colinearity, are needed to support these conclusions. 
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4. THE OXIDATION OF 8-ARYLHYPOXANTHINES BY FREE AND 
IMMOBILIZED XANTHINE OXIDASE 
4.1 INTRODUCTION 
For many years now, a primary method of gaining information about 
xanthine oxidase h a s been to s tudy its interaction with various molecules. 
This University's Department of Organic Chemistry h a s already reported on 
the oxidation of var ious 6 and 7-arylpteridin-4-ones by milk xan th ine 
oxidase [1] and bacterial xanthine oxidase [2]. Another interesting group of 
compounds is tha t made up of the pa r a - subs t i t u t ed 8-arylhypoxanthines . 
Bergman et al. [4] have described the oxidation of three of these, namely 
X = H, methyl, and nitro. Their rate of oxidation is very low compared with 
tha t of xanthine . Bergman et al. reported only relative oxidation rates , so it 
is difficult to calculate the V m a x and K m values for a larger series of 
compounds. Accordingly, part of the work done for this thesis was to obtain 
more accurate measurements of the 8-arylhypoxanthines. 
This chapter describes the effect of various pH levels, tempera tures , 
and organic solvents on the oxidation of the 8-arylhypoxanthines to the 
corresponding 8-arylxanthines by bovine milk xanthine oxidase. 
4.2 MATERIALS AND METHODS 
4.2.1 Materials 
The bovine milk xanthine oxidase (E.C. 1.2.3.2) came from Boehringer. 
The CNBr-activated Sepharose 4B came from Pharmacia . The UV spectra 
and kinet ic m e a s u r e m e n t s were made either with a Var ian DMS-100 
spectrophotometer equipped with a DS-15 da ta s tat ion, or with an LKB 
Ultrospec II spectrophotometer coupled to an Apple He personal computer. 
The IR spectra were done with a Jasco A-100 infrared spectrophotometer. 
The mass spectra were done with an AEI MS-902 appara tus . 
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4.2.2 Enzymatic Oxidation 
The xanthine oxidase assay consisted of 2.5 ml of a solution containing 
100 mM potassium phosphate buffer (pH 7.5), 0.1 mM EDTA, 90 u.g 
xanthine oxidase, and 2-30 (j.M of substrate. The oxidation rates were 
measured at various wavelengths with an LKB Ultrospec II spectro-
photometer coupled to an Apple He personal computer. Each determination 
was done in triplicate for at least six different substrate concentrations. 
The kinetic parameters were then calculated with the Hanes-Woolf 
plot [5] on a Varian DS-15 computer station using the Enhanced Kinetics 
Calculations Program (85-100542-00). The appropriate wavelengths and 
corresponding mean molar differential-absorption coefficient for the 
measurements of the oxidation rates of the 8-arylhypoxanthines were 
determined with a DMS-100 spectrophotometer (Table 4.1). 
The xanthine oxidase was then immobilized on n -oc ty lamine 
Sepharose 4B according to previously described methods [6]. The 
immobilized xanthine oxidase was packed in a small column (approximately 
1.5 ml) and used to oxidize some 8-arylhypoxanthines. The flowrate was so 
much optimized that the column was able to convert all the xanthine at the 
beginning of the experiment. 
Table 4.1 Wavelength and Molar-Extinction Coefficient Used for the Enzymatic 
Assays of Some 8-Arylhypoxanthines 
No. 
4.1a 
4.1b 
4.1h 
X 
H 
C H 3 
Br 
pH 
7.5 
8.0 
8.4 
8.8 
7.5 
8.0 
8.4 
8.8 
7.5 
8.0 
8.4 
8.8 
Wavelength (nm) 
319 
321 
325 
324 
323 
323 
325 
326 
329 
330 
332 
332 
Log 8e 
4.061 
4.037 
4.004 
3.995 
3.862 
4.049 
4.079 
4.083 
3.886 
3.916 
4.064 
4.053 
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4.3 RESULTS AND DISCUSSIONS 
Xanthine oxidase causes a very slow oxidation of the 8-arylhypo-
xanthines (4.1) at position 2, producing 8-arylxanthine (4.2). This finding, 
illustrated in Scheme 4.1, was proved by the iH-NMR spectra of the isolated 
product (4.2a), which showed that the characteristic single absorption of 
H-2 at 8 = 8.1 ppm is missing. 
Xanthine 
Oxidase 
4.2a-k 
X 
a: H 
b: CH 3 
c: /-C3H7 
d: n-C4H9 
e: 
f: 
h: 
X 
/-C4H9 
F 
CI 
Br 
X 
i: NO2 
J: N(CH3)2 
k: OCH3 
Scheme 4.1 
Because the reaction rate of xanthine oxidase with the 8-arylhypo-
xanthines is so slow, only a few of the compounds that had been synthesized 
earlier (Chapter 2) were suitable for detailed experiments on kinetic 
parameters. Consequently, this thesis describes the oxidation pattern of only 
three of the 8-arylhypoxanthines, namely the unsubstituted compound 4.1a 
(X = H), the p-methyl compound 4 .1b (X = CH3), and the p - b r o m o 
compound 4.1 h (X = Br). 
Often, a slow oxidation rate means that a compound has a low affinity 
for the enzyme, but 4.1a, 4.1b, and 4.1h have a low Km value, which 
indicates that the binding between xanthine oxidase and the 8-arylhypo-
xanthines is very tight (Table 4.2). 
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Table 4.2 Influence of pH on the Km and V m a x Values of 8-
Arylhypoxanthines at 30°C a) 
No. 
V 
pH = 7.5 
max K 
pH = 8.0 
m 'max K 
pH = 8.4 
m 'max K m 
pH = 8.8 
Vmax Km 
4.1a 
4.1b 
4.1h 
Xanthine 
0.99 0.28 
25.9 0.08 
1.40 
0.63 
1.17 
44.7 
0.60 
0.19 
0.34 
3.22 
1.79 
0.96 
1.40 
55.0 
0.97 
0.11 
0.26 
8.46 
2.45 
1.30 
2.14 
68.1 
0.47 
0.26 
0.10 
19.44 
a) Km (nM) and Vmax (10 "2 nmole/min/mg protein) were measured using assays as described in Materials 
and Methods. 
Figure 4.1 illustrates the effect of pH on the V m a x of xanth ine oxidase 
with var ious subs t r a t e s . All of the curves show t h a t oxidation activity 
increases with pH. The K m values of the 8-arylhypoxanthines, however, do 
not change as profoundly with pH as do those of xanthine. 
Although it would have been interesting to test the oxidation pat tern 
of the 8-arylhypoxanthines at a higher pH for a maximum V m a x or K m , the 
capacity of the phosphate buffer would not have been sufficient under such 
conditions. Table 4.3 presents the V m a x and K m values of 8-phenylhypo-
Vmax(10 |imole/min./mg) 
3 
Vmax (nmole/min./mg) 
r-o.7 
pH 
Figure 4.1 Effect of pH on the oxidation rate of xanthine oxidase with 
various substrates. (Assays were performed as described 
in Materials and Methods. The substrates used were 1.) 
xanthine (right Y axis), 2.) 8-phenyl-hypoxanthine, 3.) 8-
(pBr-phenyl)hypoxanthine, and 4.) 8-(pCH3-phenyl)hypo-
xanthine.) 
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xanthine (4.1a) in different buffer systems. The oxidation rate of 8-phenyl-
hypoxanthine is considerably lower in Tris-HCl buffer and borate buffer than 
in phospha te buffer. The K m value is also lower. This means tha t , as the 
buffer solution affects the oxidation of the 8-arylhypoxanthines by xanthine 
oxidase, it is virtually impossible to compare the V m a x and K m values at a 
higher pH, when the buffer solution is different. 
Table 4.3 V m a x and Km Values of 8-Phenylhypoxanthine at 30°C in Different 
Buffer Systems a) 
Buffer pH 
'max K m 
Phosphate 
Tris/HCI 
Borate 
6.9 
7.5 
8.0 
8.4 
7.6 
8.0 
8.5 
8.5 
9.0 
9.5 
0.50 
0.99 
1.40 
1.79 
0.30 
0.30 
0.90 
0.90 
1.10 
1.50 
0.13 
0.28 
0.60 
0.97 
0.10 
0.12 
0.11 
0.18 
0.18 
0.19 
a) Km (u.M) and Vm ax (10 '2 (imole/min/mg protein) were measured using 
assays as described in Materials and Methods. The ionic strength of all the 
buffers was 0.01 
Table 4.4 shows the influence of temperature on the V m a x and Km 
va lues of the 8 -a ry lhypoxan th ines . The V m a x va lues increase with 
temperature . The K m values also increase, except for the bromo compound 
(4.1h), where K m is lower at 30°C than at 25°C or 37°C. 
Table 4.4 Influence of Temperature on the Km and V m a x Values at pH 8.8 a) 
No. T = 20°C 
Vmax Km 
T = 25°C 
Vmax Km 
T = 30°C 
Vmax Km 
T = 37°C 
Vmax Km 
4.1a 
4.1b 
4.1h 
1.03 0.24 1.48 
0.90 
1.51 
0.18 
0.07 
0.18 
2.45 
1.30 
2.14 
0.47 
0.26 
0.10 
4.27 
2.67 
3.65 
0.9 
0.31 
0.29 
a) Km (|iM) and V m a x (10 "2 nmole/min/mg protein) were measured using assays as described in 
Materials and Methods. 
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To isolate the enzymatic product of the 8-arylxanthine for further 
analysis and characterization, a reaction was set up on a small, laboratory 
scale (approximately 1 g). For these exper iments , x a n t h i n e oxidase 
immobilized on n-octyl CNBr-activated Sepharose 4B was used. Because they 
enhance the solubility of subs t ra tes , various alcohols and DMSO were also 
tested for their effectiveness as organic cosolvents. 
Only low percentages of organic cosolvent were used, for experiments 
have shown tha t the initial oxidation rate decreases considerably if the 
concentration of the organic cosolvent is more than 10% (Table 4.5). 
Table 4.5 Initial Enzymatic Activity of Xanthine Oxidase in the Presence of Organic 
Cosolvents 
Organic Solvent3) Percentage (v/v) 
0% 5% 10% 15% 20% 30% 50% 
Ethanol 100% 89% 67% 46% 27% 18% <5% 
2-Butoxyethanol 100% 88% 59% 53% 44% 40% 
a)The water part of the solvent system contained 50 mM phosphate buffer (pH 8.1) and 
50 |iM EDTA. The xanthine concentration was 65 |j.M. 
Except for 10% 2-butoxyethanol and 20% n - p r o p a n o l , o rgan ic 
cosolvents do not slow the oxidation rate during long reactions (Table 4.6). 
Interestingly enough, with 10% n-propanol and 10% DMSO, immobilized 
xanthine oxidase has even more operational stability, proof that 10% DMSO 
is an effective organic cosolvent in the enzymatic oxidation of the 8-
arylhypoxanthines. 
The subs t ra t e s were dissolved in 25 mM phospha te buffer (pH 8.1) 
containing 50 U.M EDTA and 10% DMSO at a concentra t ion of 10 mM 
(approximately 2 gr/l tr) . At a flow rate of 15 ml /hour , a complete oxidation 
of compounds 4.1a, 4.1b, and 4 .1h was possible for approximately 20 hours . 
Based on the UV spec t ra of the p roduc t s t r eam, t he se convers ion 
percentages mean tha t about 600 mg of the compounds were ult imately 
oxidized into the corresponding 8-arylxanthines (4.2). 
Additional evidence of 8-arylxanthine formation was obtained from the 
isolation and subsequent s t ructure identification of compound 4.2b by *H-
NMR and IR spectra. The JH-NMR spectrum of this compound was missing 
a singlet absorption of H-2 around 8 ppm. The IR spectrum showed a double 
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Table 4.6 Half-Lives of Immobilized Xanthine Oxidase with Different Organic 
Cosolvent During Continuous Catalysis 
Solvent System3) Timeb) Half-Lifec) 
(100% conversion) 
100% water 10 hours 13.5 hours 
10% ethanol 12 hours 23 hours 
10% n-propanol 18 hours 27 hours 
10%f-butanol 11 hours 13.5 hours 
10% 2-butoxyethanol 6 hours 8 hours 
10% dimethylformamide 10 hours 15 hours 
10% dimethylsulfoxide 29 hours 43 hours 
20% n-propanol 2 hours 5 hours 
a)The water part of the solvent system contained 50 mM phosphate buffer (pH 8.1) and 50 uJvl 
EDTA. The xanthine concentration was 65 u.M. The flow was so much optimized that the 
column was able to convert all the xanthine at the beginning of the stability test. 
b)Time at which the column starts to convert less then 100% of the xanthine. 
c)Time at which the column starts to convert only 50% of the xanthine. 
absorp t ion peak a round 1700 c m - 1 and an addit ional broad b a n d a t 
3 5 0 0 c m " 1 . It is especially th i s double absorpt ion at 1700 c n r 1 t ha t 
indicates the presence of two C = O groups in the molecule. The IR 
spectrum of compound 4.2a showed a broad-band absorption at 3500 c n r 1 
and a b road-band absorpt ion at 1700 cm- 1 . In cont ras t , the s ta r t ing 
compound (4.1a) had only a narrow absorption peak at 1700 cm - 1 . 
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QSAR STUDIES OF THE INHIBITION OF FREE XANTHINE 
OXIDASE BY 8-ARYLHYPOXANTHINES 
5.1 INTRODUCTION 
The synthesis of the 8-arylhypoxanthines (5.1a-k) was described in 
Chapter 2 of this thesis. Their oxidation into 8-arylxanthines (5.2a-k) by 
xanthine oxidase was described in Chapter 4. Unfortunately, only a few of 
these compounds were suitable for more detailed studies of oxidation by 
xanthine oxidase. This was because the 8-arylhypoxanthines had very low 
reaction rates, which made it difficult to measure accurately the enzymatic 
parameters Km and V m a x and examine the influence of the substituents (X) 
on those parameters. 
The very low Km values obtained during oxidation indicate a tight 
binding between the 8-arylhypoxanthines and xanthine oxidase [1]. 
Nevertheless, the V m a x and Km values do not give sufficient quantitative 
information about the binding and interact ion between the 
8-arylhypoxanthines and xanthine oxidase. Accordingly, the initial purpose 
of the experiments described here was to assess how well the 
8-arylhypoxanthines inhibit the ability of xanthine oxidase to convert 
xanthine to uric acid. 
The V m a x of the 8-arylhypoxanthines is so low that, in the time it 
takes to inhibit the oxidation of xanthine, one would expect only a negligible 
amount of the 8-arylhypoxanthines to have been oxidized. Because of their 
strong affinity for xanthine oxidase, it is assumed that the 8-arylhypo-
xanthines can compete successfully with xanthine for the active sites of the 
enzyme, thus inhibiting the oxidation of the substrate (xanthine) upon 
binding. The resulting inhibition constants would then reflect the effect of 
the substituents (X) at the para position of the aryl group on the interaction 
between the 8-arylhypoxanthines and xanthine oxidase. 
Although the literature contains a few isolated reports of 8-arylhypo-
xanthines with a remarkably low I50 value for xanthine oxidase [2], no 
comprehensive study of them has ever been made. 
The inhibition constants for the 8-arylhypoxanthines supplement 
previous research [3] on the inhibitory properties of the 6-p-X-arylpteridin-
4-ones (5.3). Chapter 3 describes how it was possible to calculate a 
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quantitative structure-activity relationship (QSAR) for the para substituents 
of these compounds and thus accurately predict that rod-shaped alkyl 
substituents like n-butyl would be more tightly bound to inhibitors. The 
basic structure of the 8-arylhypoxanthines has two features in common with 
that of the 6-arylpteridin-4-ones. These are: 
- A heterocyclic system with a pyrimidine ring and a hydroxy group at 
position 4; 
- A pyrimidine ring fused at the 5,6-bond with another heterocyclic ring 
system (pyrazine in the 8-arylhypoxanthines or an imidazole in the 6-
arylpteridin-4-ones). 
The oxidation pattern of both compounds leads one to assume that 
they will be fixed to the enzyme at the pyrimidine part [4]. Other studies [5] 
seem to indicate that the aryl group is instrumental in a tight enzyme-
inhibitor complex. The main difference between the two compounds is that, 
in the 8-arylhypoxanthines, the aryl group aligns with the heterocyclic ring 
system (parallel to the X axis) and, in the pteridine system, it forms an angle 
with the heterocyclic ring system (Figure 5.1). 
Consequently, the inhibition experiments done for this thesis had a 
twofold purpose; they would establish whether the structural difference 
between the 6-arylpteridin-4-ones and the 8-arylhypoxanthines affects the 
affinity of xanthine oxidase for these two compounds and they would shed 
more light on the interaction between the aryl group and the hydrophobic 
area in the enzyme. 
Y 
5.1a-k 
N 
H H 
5.2a-k 
*v // 
Figure 5.1 Orientation of the aryl-substituent in the 6-arylpteridin-4-ones 
and the 8-arylhypoxanthines. 
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5.2 MATERIALS AND METHODS 
5.2.1 Materials 
The milk xanthine oxidase was purified out of raw, unpasteurized milk 
from this University's farm according to the method described by Massey et 
al. [6]. The enzyme was purified to a specific activity of 1.42 u n i t s / m g 
protein. The AFR value was 65 [7]. The xanth ine came from Fluka. The 
allopurinol came from Sigma. All the other chemicals were analytical grade 
from Merck. 
5.2.2 Enzyme Assays 
The ra tes were measured with a Beekman DU-7 spectrophotometer 
equipped with a Kinetics module and a thermosta t ted cell holder (25°C). 
The inhibition of the conversion of xanthine into uric acid was measured at 
296 nm (Se = 10.19 mM.cnr 1 ) . The assays were performed in 0.1 M sodium 
phosphate buffer (pH 7.5, 0.1 mM EDTA), consisting of 60 |iM xan th ine , 
20 ng/ml xanthine oxidase, and appropriate amounts of inhibitor in a final 
volume of 2.5 ml. The I50 values (i.e. the concentration at which a compound 
shows an inhibition of 50%) were calculated by l inear regression of the 
reaction rate versus the log value of the inhibitor concentration. 
5.3 RESULTS 
5.3.1 Inhibition of Xanthine Oxidase 
The initial inhibition experiments tested the effect of pH levels on the 
enzymatic oxidation of the 8-arylhypoxanthines into 8-arylxanthines. The 
results showed that the rate of oxidation slows as the pH decreases (Figure 
5.2), dropping to almost zero under nearly neutral or acid conditions. As the 
oxidat ion r a t e also slows at lower t e m p e r a t u r e s [8], s u b s e q u e n t 
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r^nax 0 0 jimole/min./mg) 
3 
Vmax (nmole/min./mg) 
0.7 
pH 
Figure 5.2 Effect of the pH on the oxidation rate of xanthine oxidase 
with various substrates. Assays were performed as 
described in Materials and Methods. The substrates used 
were 1.) xanthine (right Y axis), 2.) 8-phenylhypoxanthine, 
3.) 8-(pBr-phenyl)hypoxanthine, and 4.) 8-(pCH3-
phenyl)hypoxanthine. 
experiments were performed at a pH of 7.5 and a temperature of 25°C [9]. 
The inhibition of xanthine oxidase begins at very low concentrations of 
the 8-arylhypoxanthines. In fact, a significant decrease in oxidation occurs at 
equimolar concentrations of the enzyme and inhibitor, which is a clear 
indication that the inhibitor is very tightly bound. Some 8-arylhypo-
xanthines, namely X = F, Br, and t-butyl, reduced the enzymatic activity to as 
little as 10% at inhibitor concentrations only ten times higher than the 
enzyme concentration. 
At such low concentrations of the inhibitor, the Lineweaver-Burk 
equation is not suitable for calculating the kinetic parameters. This 
equation, which is based on Michaelis-Menten kinetics, assumes that there 
is no depletion of the inhibitor by the enzyme during oxidation. In other 
words, it does not allow for the possibility that the binding of the inhibitor 
to the enzyme can significantly change the concentration of the free 
inhibitor. 
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The resul ts of the experiments were even more difficult to analyze 
because of the non-linear initial rates of the oxidation of xan th ine in the 
presence of an inhibitor, which made it impossible to use the Dixon plot for 
tightly-bound inhibitors [10]. This problem was circumvented by expressing 
inhibition as I50 values (i.e. the concentration of the inhibitor a t which the 
enzymatic oxidation of xanthine is reduced by 50%). The I50 values of the 
8-arylhypoxanthines (Table 5.1) were calculated by measur ing the initial 
oxidation rate of 60 |J.M xanthine and 20 | ig /ml protein in at least twelve 
different concentrat ions of the inhibitor. 
Table 5.1 I50 and I90 Values of the 8-Arylhypoxanthines and 8-Arylxanthines a) 
No. 
5.1a 
5.1b 
5.1c 
5.1d 
5.1e 
5.1f 
5.1g 
5.1h 
5.1 i 
5.1J 
5.1k 
X 
H 
F 
Cl 
Br 
CH 3 
'-C3H7 
n-C4H9 
f - C ^ g 
N 0 2 
N(CH3)2 
OCH3 
Allopurinol 
6-Phenylpteridin-4-
8-Arylhypoxanthine 
I50 (HM) 
0.21 
0.04 
0.06 
0.01 
0.07 
0.17 
0.09 
0.03 
0.16 
0.10 
0.11 
4.91 
one 1.70 
8-Arylxanthine 
I50 (IAM) b) 
1.91 
1.87 
1.24 
0.55 
2.12 
1.27 
0.75 
2.14 
4.22 
1.49 
3.12 
13.21 
I90 (HM) b) 
27.68 
25.04 
16.49 
12.63 
14.43 
13.20 
88.70 
20.90 
43.60 
26.80 
30.50 
a)Assays were performed with 60 uM xanthine and 20 u.g/ml xanthine oxidase (AFR = 65 [7]). 
bjThese I50 and I90 values were measured after preincubating the inhibitor with xanthine 
oxidase for an appropriate time (at least one hour for the lower concentrations), to ensure 
that the inhibitor was oxidized to the corresponding 8-arylxanthine. 
The experiments revealed that a sudden increase occurs in the rate of 
the oxidation of xanthine by the 8-arylhypoxanthines (Figure 5.3). The time 
that elapses between the start of the reaction and this increase (indicated by 
the arrows) depends on the concentration of the inhibitor. One can assume 
then that , at the moment of increase, all of the inhibitor will have been 
oxidized to the corresponding 8-arylxanthines (5 .2a-k) and tha t these 
p roduc ts are a less effective inhibitor of xan th ine oxidase t h a n the 8-
arylhypoxanthines. 
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Absorbance 
0.7 
1 • 1 
50 60 
Time (min) 
Figure 5.3 Time scan of the inhibited oxidation of xanthine by 8-(pN(CH3)2-
phenyl)hypoxanthine. The xanthine oxidase assays were 
performed as described in the section on materials and methods. 
The inhibitor concentrations used were 1.) 0 u.M. and 0.078 uM, 
2.) 0.156 u.M. 3.) 0.391 u.M. 4.) 0.703 nM, 5.) 1.016 uM, and 6.) 
1.641 u.M. The arrows indicate the moment at which a sharp 
increase in the oxidation rate occurs. 
Some of the experiments on inhibition involved testing the 8-aryl-
xanthines. In these experiments, the enzyme was preincubated with the 
8-arylhypoxanthines in the phosphate buffer for one to six hours, during 
which time the 8-arylhypoxanthines were converted fully into the 8-aryl-
xanthines. Subsequently, the inhibitory activity of the 8-arylxanthines was 
measured, with xanthine as the substrate. The results (Table 5.1) indicate 
that the I50 values of the 8-arylxanthines are ten to fifty times greater than 
those of the 8-arylhypoxanthines, but still considerably smaller than those of 
allopurinol or the 6-arylpteridin-4-ones [3]. 
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It is r emarkab l e t ha t p r e incuba t i on of the enzyme in a low 
concen t ra t ion of compound 5 . 1 a - k (< 150 nM) c a u s e s no significant 
decrease in the enzymatic oxidation rate of xanthine and tha t preincubation 
without compound 5.1a-k causes a decrease of around 5%. This means tha t 
low concentrat ions of the 8-arylhypoxanthines do not affect the activity of 
xanthine oxidase. 
5.3.2 QSAR Analysis 
The I50 values for the 8-arylhypoxanthines vary greatly. To form a clear 
picture of the effect of the subst i tuents on the aryl group, these values were 
used to calculate the QSAR of compounds 5. la-k and 5.2a-k. Table 5.2 shows 
the results of these calculations for compound 5 . 1 . 
Table 5.2 QSAR Calculation for the Inhibition of Xanthine Oxidase by Substituted 
8-Arylhypoxanthines 
I50 =-0.105 6! +0.256 L-0.038 o-0.180 (5.1) 
(t = 2.0) (t = 1.2) (t = 0.7) 
n = 11 r = 0.606 s = 0.065 F = 1.36 
I50 = 0.114 MTD* +0.073 (5.2) 
(t = 5.2) 
n = 11 r = 0.866 s = 0.036 F = 26.96 
Equation 5.1 gave the best possible results . It is based on the Hansch 
parameters and the steric parameters of the Sterimol method (Chapter 1). 
The intercorrelation of these parameters is shown in Table 5.3. The number 
of parameters was limited to three because only eleven compounds were 
available. Equation 5.1 has no statistical significance because r and F are very 
low. 
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Table 5.3 Squared-Correlation Matrix Showing the Degree ot Colinearity (r2) 
Between the Variables Used 
G Bi (MR)" 
K 
a 
L 
B1 
(MR)2 
1.000 0.287 
1.000 
0.729 
0.175 
1.000 
0.659 
0.140 
0.362 
1.000 
0.843 
0.440 
0.778 
0.525 
1.000 
Equation 5.2 is based on the MTD* method (Chapter 1). Although the 
MTD* parameters seem to explain all the I50 values, they give no predictive 
values outside the congeneric group. 
The steric requirements for a good inhibitor are listed in Figure 5.4. 
They give an idea of other subst i tuents only as long as these subs t i tuents fit 
into the hypermolecule. One example is the 8-(pCN-phenyl)hypoxanthine , 
which h a s an MTD* value of zero. Unfortunately an a t tempt to synthesize 
this compound was unsuccessful (Chapter 4). 
3—5, 
1,2, 
4,5, 
3 
Are favorable 
Are indifferent 
Is unfavorable 
Structure 
phenyl 
pF-; pCI-; pBr-phenyl 
pCH3-phenyl 
pOCH3-phenyl 
p/Pr-; pNCVphenyl 
pN(CH3)2-phenyl 
pnC4H9-phenyl 
p f C ^ g - p h e n y l 
Occupied Position 
1 
1 2 
1 2 
1 2 3 
1 2 3 4 
1 2 3 4 
1 2 3 5 6 
1 2 3 4 7 
MTD* 
2 
1 
1 
2 
2 
2 
2 
1 
Figure 5.4 Hypermolecule for all the positions of the 8-arylhypoxanthines. 
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When Equation 5.2 is applied to the 8-arylhypoxanthines, the results 
show that the linear alkyl substituents do not bind well with xanthine 
oxidase. This is contrary to the results for the 6-arylpteridin-4-ones (5.3), 
which showed that the n-butyl substituents had a very low Kj value (Chapter 
3). The I50 values of the 8-arylhypoxanthines in Table 5.1 are approximately 
ten to a hundred times lower than those of the 6-arylpteridin-4-ones. For a 
view of the real biological activity of the 8-arylhypoxanthines, one would also 
have to study the inhibitory properties of the oxidized 8-arylhypoxanthines. 
Table 5.1 lists the I50 and I90 values for the 8-arylxanthines. The I90 
values were included because it was not possible to calculate a significant 
QSAR equation for the I50 values. The QSAR equations for the I90 values are 
shown in Table 5.4. Equation 5.3 uses two Hansch parameters, namely MR 
and a, where o~ has a large positive coefficient, and the Sterimol parameter 
B i , which has a large negative coefficient. With this combination of 
coefficients, "bulky" substituents with a small a value will stimulate the 
formation of an enzyme-inhibitor complex. Equation 5.4, which is based on 
the MTD* approach, makes roughly the same prediction(Table 5.4). 
Table 5.4 QSAR Calculation for the Inhibition of Xanthine Oxidase by 
Substituted 8-Arylxanthines 
I90 = 
I90 = 
0.200 MR - 53.288 B-, + 45.564 0 + 90.768 
(t = 6.3) (t = 5.4) (t = 4.2) 
n = 11 r = 0.926 s = 6.15 
-8 .663 71 + 39.154 MTD* - 0.073 
(t = 5.2) (t = 8.1) 
n = 11 r = 0.948 s = 7.77 
F = 14.22 
F = 35.33 
(5.3) 
(5.4) 
The steric requirements (Figure 5.5) show that xanthine oxidase 
tolerates occupancy of positions 2, 3, 4, and 7 and that it allows binding to 
the 8-arylxanthines more readily if the substituents have a hydrophobic 
property. 
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Figure 5.5 Hypermolecule for all the positions of the 8-arylxanthine. 
5.4 DISCUSSION 
The inhibitory performance of the 8-arylhypoxanthines and the 8-
arylxanthines shows that their affinity for xanthine oxidase is much greater 
than that of the 6-arylpteridin-4-ones and allopurinol. As stated above, the 
main steric difference between the 8-arylhypoxanthines and the 6-
arylpteridin-4-ones is the position of the aryl group in relation to the 
heterocyclic system. The linear molecules, namely the 8-aryl(hypo-)xan-
thines (5.1a-k and 5.2a-k), show a greater affinity for xanthine oxidase than 
the non-linear molecules, namely the 6-arylpteridin-4-ones (5.3). Leonard 
et al. [11] observed a similar phenomenon when they tested "stretched-out" 
analogs of hypoxanthine as substrates of xanthine oxidase (Figure 5.6). The 
linear molecule ün-benzohypoxanthine (5.4) reacted faster than the angular 
molecule prox-benzohypoxanthine (5.5). Leonard et al. also observed that 
the other angular molecule, dist-benzohypoxanthine (5.6), reacts just as fast 
as the îm-benzohypoxanthine. The 7-arylpteridin-4-ones have a geometrical 
conformation similar to that of the dist-benzohypoxanthine, but show no 
inhibitory properties, for they are well oxidized by xanthine oxidase. The 
Km value of the dist-benzohypoxanthine is of the same order as the Kj value 
of the 6-arylpteridin-4-ones [3]. 
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'1 1 NH 
N HN' 
H 
5.4 5 .5 
5.6 
Figure 5.6 Stretched-out analogs of hypoxanthine. 
A detailed discussion of the effect of the subs t i tuen t s is not possible 
because both the availability of the required compounds and the predictive 
capacity of QSAR Equations 5.2 and 5.4 are limited. In general, however, the 
subs t i tuen ts of the 8-arylhypoxanthines tha t have an affinity for xanth ine 
oxidase are those tha t are linear in relation to the X axis of the molecule 
(Figure 5.1). The 8-arylxanthines, tha t have an affinity for xanth ine oxidase 
are those with a fairly short subst i tuent . This affinity is enhanced by the 
hydrophobic character of the subst i tuents . 
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GENERAL DISCUSSION 
This thesis presents the results of experiments on the synthesis of the 
6-arylpteridin-4-ones and the 8-arylhypoxanthines, an analysis of how well 
these compounds inhibit the active site of bovine milk xanthine oxidase, and 
a description of how a quantitative structure-activity relationship (QSAR) 
was developed to explain their inhibitory activity further. This chapter 
contains a review of the chemical synthesis of the 6-arylpteridin-4-ones and 
the 8-arylhypoxanthines, followed by an analysis of their inhibitory 
properties. 
6.1 CHEMICAL SYNTHESIS 
For this thesis, simplicity was a primary consideration in the chemical 
synthesis of the 8-arylhypoxanthines and the 6-arylpteridin-4-ones. This 
was to facilitate possible future use of the compounds. A feature common to 
both compounds is the pyrimidine ring, which means that, for the 
synthesis, one can use the same starting material, namely 4,5-diamino-
pyrimidin-6-one (6.1). 
HOOC—(v ,)—X 
O 
H N ^ y N H 2 
6.1 
CICO—(x /)—X 
6.2 
N C
-
C
~ \ \ / / - X 
Scheme 6.1 Synthetic pathways of 8-arylhypoxanthines and 6-
arylpteridin-4-ones. 
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To synthesize the 8-arylhypoxanthines, a condensation of 4,5-diamino-
pyrimidin-6-one (6.1) with a substituted benzoic acid was sufficient to 
obtain the required 8-arylhypoxanthines (6.2). The dehydration for this step 
requires polyphosphoric acid, which works conveniently with several 
substituted benzoic acids. In an attempt to extend the series of 8-
arylhypoxanthines with other substituents, substituted benzoylchlorides 
were used instead of substituted benzoic acid. Although the formation of the 
intermediate 4-amino-5-arylamidopyrimidin-6-one was attained for several 
substituted aryl groups, the subsequent ring closure of various 4-amino-5-
arylamidopyrimidin-6-ones into the required hypoxanthines was 
troublesome. In some of the unsuccessful experiments, 4-amino-5-
arylamidopyrimidin-6-one was recovered and, in others, compound 6.1 and 
arylcarboxylic acid were found in the reaction mixture. 
The 6-arylpteridin-4-ones (6.3) were conveniently synthesized by 
reacting compound 6.1 with an arylglyoxal in 96% ethanol at pH 2.7 
(Chapter 2). The main drawback of this method is that, besides compound 
6.3, one always obtains the isomeric 7-arylpteridin-4-one. A suitable way to 
separate the two isomers is by recrystallization from DMSO. De Meester et 
al. [1] developed an unequivocal synthesis of the 6-arylpteridin-4-ones, in 
which they used appropiately substituted pyrazine N-oxides as starting 
materials [2]. Difficulties in synthesizing some of the N-oxides, however, 
made it impossible to obtain more than a very few substituted 6-
arylpteridin-4-ones. 
6.2 INHIBITORY PROPERTIES 
Xanthine oxidase has been intensively studied [3]. It consists of two 
identical subunits [3a], each of which has a molybdenum-pteridin, an FAD 
(Flavine Adenine Dinucleotide), and two iron-sulfur centers as cofactors. 
Xanthine oxidase is interesting to synthetic chemists because it catalyzes 
the hydroxylation of a wide variety of purines and pteridines. The 
mechanistic questions concerning the enzymatic reactions have been the 
subject of many biochemical studies. 
Notwithstanding the work of biochemists, the picture of the reaction 
of xanthine oxidase with reducing substrates is still incomplete. The 
reduction of xanthine oxidase by xanthine occurs by electron transfer [4], 
68 
The currently accepted number of electrons taken up by a fully reduced 
enzyme is six per subunit: two to molybdenum, two to flavin, and one to 
each iron-sulfur center. Thus it would require three molecules of substrates 
reacting sequentially to generate the six-electron reduced enzyme [5], 
At which sites, then, is there a possible interaction of substrates 
(either reducing or oxidizing) with the three prosthetic groups of xanthine 
oxidase? Olson et al. [6] concluded that the iron-sulfur centers act as 
electron sinks during turnover to keep molybdenum oxidized and flavin 
reduced. Bray [3b] supports these findings and even suggests that the iron-
sulfur centers may be buried within the molecule. This means that only the 
molybdenum and the flavin cofactors are available for interaction with 
substrates. Other investigators [7] have argued that all the prosthetic groups 
can interact with substrates. 
These controversies reflect very well the state of the research on 
xanthine oxidase. There seems to be a general agreement on the action 
mechanism, but the reaction mechanism has yet to be described to 
everyone's satisfaction. It is in this context that compounds 6.2 and 6.3 
were used to increase knowledge of the enzyme. Because both sets of 
compounds are slowly oxidized by xanthine oxidase at the C-2 position 
(Figure 6.1), the assumption is that these compounds interact at the 
molybdenum site (Chapters 3 and 4). 
6 7 
1 Nf 
•03 
3 
H
 9 1 8 
6.4 6 .5 
Figure 6.1 Numbering of the purine and pteridine ring systems. 
Robins et al. [8] recently proposed a model of the interaction of 
molybdenum with organic compounds. This model includes the pterin 
cofactor with molybdenum to propose a kinetic model of the oxidation of 
hypoxanthine and xanthine (Figures 6.2 and 6.3). The pterin cofactor brings 
the enzymatic nucleophilic site and the molybdenum atom in the active 
pocket together in the right orientation for the oxidative reaction. The 
model has two types of substrate binding: type 1 and type 2. Figure 6.2 
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XX 
Mo 
H H 
IV 
HO H O 
— C - C - O - P - O H 
H H OH Mo' 
Figure 6.2 Binding pattern of xanthine with molybdopterin and oxidation 
of xanthine into uric acid by xanthine oxidase. (After Robins 
et al. [8].) 
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Figure 6.3 Binding pattern of hypoxanthine with molybdopterin and 
oxidation of hypoxanthine into xanthine by xanthine oxidase. 
(After Robins et al. [8].) 
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shows how xanthine binds with the molybdopterin cofactor at 0-6 and N-7 
in a type I binding. Figure 6.3 shows how hypoxanthine binds with the 
molybdopterin cofactor at N-3 and N-9 in a type II binding. Either way, the 
sulfide group is oriented properly for the attack on C-8 of xanthine or C-2 of 
hypoxanthine. By varying the substitution pattern of the substrates or the 
inhibitors, one can vary the dimensions and explore the active site. 
The recent synthesis of benzo-elongated purines [9] and pteridines 
[10], and their subsequent oxidation by xanthine oxidase, shows that the 
active site can bind large compounds in a reactive binding mode. Moder and 
Leonard [11] found the spatial limit for the reactive type I binding region by 
synthesizing Zin-naphthoxanthine (6.u, Table 6.1), which is not oxidized by 
xanthine oxidase. The type II binding region seems to be larger, for lin-
naphthohypoxanthine (6.8, Table 6.2) is still oxidized to compound 6.u [11]. 
As to the binding of inhibitors by xanthine oxidase, the variation in 
size and structure is almost limitless. Table 6.1 gives some examples of the 
compounds used in the inhibition studies. 
Most of the inhibitors are modeled on a purine-type azaheterocyclic 
ring system. If one follows the numbering system of purine (6.4), the 
nitrogen atom at position 1 seems essential to the good inhibitory 
properties of a compound, for compounds 6.j-n have large I50 values. At the 
same time, an aryl substituent connected to the five-membered ring 
enhances the binding with the enzyme considerably, for compounds 6.c-h 
have smaller I50 values than compounds 6.a and 6.b. The active site is 
flexible with inhibitors, for it accommodates small compounds (6.a and 6.b) 
very well. On the other hand, it also accommodates compounds like 6.j, 6.1, 
and 6 .m , which have two aryl substituents, and the elongated lin-
naphthoxanthine (6.u). The inhibitor-enzyme complex for the larger 
compounds is not as strong as that for the smaller compounds because the 
I50 and Kj values are larger. Nevertheless, the enzyme is still able to 
accommodate that type of inhibitor in the active site. Mono-aryl compounds 
with a type II binding seem to bind better with the enzyme than those with 
a type I binding (compare, for example, compounds 6.2 and 6.f, which have 
a type II binding, with 6.e, which has a type I binding, or compare 
compound 6.h with 6.i). One explanation of this could be that the aryl 
substituent in a type II binding has a better interaction with the 
hydrophobic "wall" of the active site than the aryl substituent in a type I 
binding. 
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Table 6.1 Hypoxanthine, Xanthine, and Pteridine Analogs as Inhibitors of Xanthine 
Oxidase 
No. Compound I» (MM) Ref. 
6.a 
6 .b 
6.c 
6 .d 
6 .e 
6.f 
O 
HN" TT- ^ 
-UT L iL'
N 
H 
HN 
k ^ 
XXX> 
H , N ' "-N' 
XX7 H 2 N ' ^ N -
HN N 
N 
HN' 
k \ ) _ S C H 2 - ^ v A 
4.9 
8.4 
R = H 0.41 
R = pCI 1.8 
1.1 
13 
2.8 
12 
12 
13 
13 
14 
15 
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No. Compound Iso(MM) Ref. 
6.2 
6.g 
6.h 
6.i 
6. j 
6.k 
6.1 
HN' 
k 
H 
^ // 
R = H 0.209 
R = Br 0.010 
R = H 1.9 
R = Br 0.55 
0.047 
80 
40 
R,= H R2=CH 11 
R,= H R2= N 45 
R,= CI R2= CH 24 
R,= CI R2= N 78 
R,= OH R2=N>150 
91 
16 
16 
17 
18 
19 
20 
19 
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No. Compound ISO(MM) Ref. 
6.m 
6 .n 
6 . 0 
6.p 
6.q 
6.3 
6.r 
j*r^ 
H N ^ N ^ 
H3CS 
O 
A. HN' ^ N 
O 
H3CO 
HN 
N 
k 
HN 
N .CHO 
H2N' ^ N T ^ N ^ " 
160 
R1 = CH3 ;R2 = CH; >120 
R3=N 
R1 = H;R2=N; 50 
R3=CH 
1.4 
21 
80 
R = H 0.17 
R = nC4H9 0.15 
K| = 6x 10"4u:M 
19 
21 
22 
23 
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No. 
6.S 
6. t 
6.U 
6.V 
6.W 
Compound 
O 
H2N^rA 
o 
o 
" " T T ' 
H 
> 
JlVR 
F 3 C>-N 
s* 
1 N 
H 
H 
- N 
H 
l»(nM) 
R = H 0.9 
R = CH3 1.2 
R = CHO 0.07 
1.1 
*Ki =4.03|iM 
R = C6H5 20 
R = pCIC6H4 10 
R = 4-Pyridyl 2 
R = C6H5 1.0 
R = 4-Pyridyl 0.06 
R = pCIC6H4 0.6 
Ref. 
24 
25 
11 
26 
26 
Table 6.2 lists some compounds that , according to the models of 
Robins et al. [8], would have a type II binding with xanthine oxidase (Figure 
6.3). 
All of these compounds are actually substrates , although some of them, 
namely 6 .2 [5], 6 . 3 [3], and 6 .8 [9], are oxidized only slowly by xanth ine 
oxidase. For compounds 6 .2 and 6 . 3 , an interaction with the wall of the 
active site is assumed because the different aryl subs t i tuen ts have a large 
influence on inhibitory capacity. The hydrophobic character of this wall is 
underscored by the absence of electronic parameters in the QSAR equations 
for compounds 6 .2 and 6 . 3 . The inhibition of xanthine oxidase seems to be 
governed mainly by steric factors. Xanthine oxidase favors bulky subst i tuents 
at the para position of the aryl group, and there is an additional requisite for 
compound 6 .3 , namely the subst i tuent X must be rod-shaped. There are two 
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Table 6.2 Azaheterocyclic Compounds That Have a Type II Binding 
with Xanthine Oxidase 
No. Compound Inhibitor Substrate Ref. 
6.2 HN' k 
6. 3 HN' 
k 
6.6 HN 
N / = \ 
H 
R 
N. 
N " ^ N : 
O 
.N 
H 
yes c-2 
yes C-2 
no C-2;C-8 
16 
22 
27 
6.7 H N ^ ^ ^ U N C-2; C-7 11 
6.8 HN' 
k 
yes C-2 11 
no c-2 28 
6 .10 HN ÓCC C-2;C-7orC-8 10 
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slight indications of this for compound 6.2: the hypermolecule in Figure 
5.4 shows that positions 2 and 7 are favorable and that they lead to a rod-
shaped substituent. Thus it is evident that one cannot make a definitive 
statement on the nature of the hydrophobic wall based on the congeneric 
series presented in this thesis. 
Figure 6.4 shows how different aryl substituents present at different 
positions in an inhibitor can interact with the hydrophobic wall of the 
Compound 6.g 
Type I binding 
= E 
Compound 6.2 
Type II binding 
= E 
Compound 6.9 
Type II binding 
Compound 6.3 
Type II binding 
Figure 6.4 The molybdopterin active site of xanthine oxidase. A, B, C, D, 
and E are points in the hydrophobic pocket of the active site 
with which an aryl substituent (R) of the inhibitor interacts. 
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active site and how the interaction of the aryl group depends on the type 
of binding. 
For example, the 8-arylxanthines (6.g) have a type I binding, which 
means that the aryl group interacts with part E of the hydrophobic wall of 
the active site, and the 8-arylhypoxanthines (6.2) have a type II binding, 
which means that the aryl group will interact with part B. This explanation 
would clarify the difference between the I50 values of the 8-
arylhypoxanthines and those of the 8-arylxanthines. Other examples are 
the 6-arylpteridin-4-ones (6.3) and the 7-arylpteridin-4-ones (6.9), both of 
which have a type II binding. The aryl group of compound 6.3 interacts 
with part C and that of compound 6.9 interacts with part A. In addition, 
one can say that the hydrophobic interaction of the 9-arylguanines (6.c) is 
entirely different from that of the 8-arylhypoxanthines. The 9-arylguanines 
have a type I binding, which means that the aryl substituent interacts with 
the hydrophobic wall at point D. 
Figure 6.4 shows clearly that all these compounds, which appear to be 
structurally similar, interact very differently with the active site. The 
figure also shows that, with the compounds presented in this thesis, one 
is probing different parts of the active site. While the binding models of 
Robins et al. will probably not be the final proposal for the molybdenum 
active site of xanthine oxidase, they at least offer a reasonable explanation 
of the difference in the I50 values of seemingly similar compounds. Further 
research is needed to understand better the reactions catalyzed by 
xanthine oxidase. 
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SUMMARY 
This thesis contains the results of a QSAR analysis of the interaction of 
bovine milk xanthine oxidase with two azaheterocyclic compounds, namely 
the 6-arylpteridin-4-ones and the 8-arylhypoxanthines. Xanthine oxidase has 
active sites for various substrates. The studies done for this thesis were of 
the active site connected to the molybdenum cofactor. 
Chapter 2 contains a description of how the 6-arylpteridin-4-ones and 
the 8-arylhypoxanthines were prepared. To synthesize the congeneric series 
of pteridines, the Gabriel-Isay method was used. This method, in which 
4,5-diamino-6-hydroxypyrimidin reacts with an arylglyoxal, invariably led to 
contamination of the reaction product with isomeric 7-arylpteridin-4-ones. 
Multiple recrystallization from a DMSO-water solution minimizes conta-
mination of the product to less than 5%. To synthesize the 8-arylhypo-
xanthines, benzoic acid derivatives were used instead of arylglyoxal 
derivatives. 
The 6-arylpteridin-4-ones are good inhibitors of both free and 
immobilized xanthine oxidase (Chapter 3). To study the inhibitory 
properties of these compounds as expressed by their Kj values, a QSAR 
equation was calculated. The equation shows that the electronic character of 
the 6-arylpteridin-4-one substituents does not influence the inhibition of 
xanthine oxidase; it is governed only by steric factors. The QSAR equation 
also shows that the effectiveness of an inhibitor is reduced by large spherical 
substituents like r-butyl and enhanced by rod-shaped substituents like n-
butyl. For immobilized xanthine oxidase, an additional factor, namely the 
hydrophobic parameter Jt, is essential for the equation. The explanation for 
this lies in the hydrophilic character of the Sepharose matrix that is used to 
immobilize the enzyme. 
The 8-arylhypoxanthines were synthesized and tested for their 
effectiveness as substrates of xanthine oxidase (Chapter 4). During synthesis, 
the 8-arylhypoxanthines are converted into the corresponding 
8-arylxanthines. To characterize the product, the 8-phenylhypoxanthine was 
incubated with immobilized xanthine oxidase. The product of the enzymatic 
reaction was then isolated and characterized as 8-phenylxanthine by 
13C-NMR and IR spectroscopy. The oxidation of these compounds is so slow 
that a detailed study was done only for the unsubstituted compound, the 
p-methyl, and the p-bromo substituted 8-arylhypoxanthines. At a high pH 
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level, V m a x is considerably higher than at a low level and Km remains 
essentially the same. V m a x and Km are both higher at high temperatures. 
Chapter 5 contains the results of experiments on the inhibition of free 
xanthine oxidase by the 8-arylhypoxanthines. At very low concentrations, the 
8-arylhypoxanthines are effective inhibitors of xanthine oxidase. 
Consequently, the enzymatic oxidation of the 8-arylhypoxanthines 
(described in Chapter 4) heavily influences their resulting effective 
concentration. This makes it so difficult to measure the Kj parameters 
accurately that only the I50 values are given here. The 8-arylhypoxanthines 
inhibit xanthine oxidase at equimolar concentrations, and the 8-aryl-
xanthines have much higher I50 values. Therefore, because the I50 values of 
the 8-arylxanthines are similar to those of the 6-arylpteridin-4-ones, the 
8-arylhypoxanthines are just as effective at inhibiting xanthine oxidase as the 
6-arylpteridin-4-ones. 
Chapter 6 contains a comparison of the inhibitory properties of the 
6-arylpteridin-4-ones and the 8-arylhypoxanthines with those of several 
other azaheterocyclic compounds. The flexibility of the active site of 
xanthine oxidase is confirmed. The site, which contains the molybdenum 
co-factor, can accommodate compounds of different sizes. Proof of this is 
found in the inhibition of xanthine oxidase by a small compound like 
allopurinol, by larger compounds like 6-arylpteridin-4-one or 8-arylhypo-
xanthine, and by [in-naphthoxanthine, which is twice as large as allopurinol. 
With these congeneric compound series, one can also study the "wall" 
of an enzyme's active site. The interaction of the substituents of the 6-aryl-
pteridin-4-ones and the 8-aryl(hypo-)xanthines with the wall of xanthine 
oxidase's active site seems to be governed only by steric factors. This is 
because electronic parameters like o do not appear in the QSAR equations. 
The type I and type II binding models explain the large differences between 
the I50 values of the 8-arylhypoxanthines and those of the 8-arylxanthines. 
Although these compounds are structurally similar, their aryl substituent 
interacts with different parts of the active site. 
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SAMENVATTING 
Dit proefschrift handelt over een QSAR-analyse van de interactie 
tussen xanthine-oxidase uit koemelk en twee reeksen van azahetero-
cyclische verbindingen, namelijk de 6-arylpteridin-4-onen en de 8-aryl-
hypoxanthines. Xanthine-oxidase heeft verscheidene reactiecentra 
beschikbaar voor verschillende soorten verbindingen. Het onderzoek betrof 
het reactiecentrum met de molybdeen-cofactor. 
In hoofdstuk 2 wordt de synthese van de azaheterocyclische verbin-
dingen beschreven. Voor de reeks van 6-arylpteridin-4-onen werd de 
Gabriel-Isay-methode gebruikt. Bij deze methode, waarin 4,5-diamino-
pyrimidin-6-on reageert met een arylglyoxaal-derivaat, ontstaat tevens het 
isomeer 7-arylpteridin-4-on. Door meermaals om te kristalliseren uit een 
oplossing in DMSO-water was het mogelijk deze verontreiniging terug te 
brengen tot minder dan 5 procent. Bij de synthese van de 8-arylhypo-
xanthines werden benzoëzuur-derivaten gebruikt in plaats van arylglyoxaal-
derivaten. 
De 6-arylpteridin-4-onen zijn goede remstoffen van zowel vrij als 
geïmmobiliseerd xanthine-oxidase (hoofdstuk 3). De QSAR-vergelijking laat 
zien dat het elektronische karakter van de substi tuenten van de 
6-arylpteridin-4-onen geen invloed heeft op de remming van xanthine-
oxidase. De verschillen in de remmende werking worden slechts bepaald 
door sterische factoren. De QSAR-vergelijking toont aan dat de remmende 
werking verlaagd wordt door grote bolvormige substituenten, zoals t-butyl, 
en vergroot door staafvormige substituenten, zoals n-butyl. Voor 
geïmmobiliseerd xanthine-oxidase blijkt een extra factor, de hydrofobe 
parameter 7t, essentieel te zijn voor de QSAR-vergelijking. Deze extra factor 
wordt verklaard door het hydrofiele karakter van de Sepharose-matrix die 
gebruikt is voor de immobilisatie van het enzym. 
De 8-arylhypoxanthines zijn eerst bestudeerd als substraat voor 
xanthine-oxidase (hoofdstuk 4). In de enzymatische reactie worden 
8-arylhypoxanthines geoxideerd tot de overeenkomstige 8-arylxanthines. 
Om het produkt te karakteriseren is 8-fenylhypoxanthine geïncubeerd met 
geïmmobiliseerd xanthine-oxidase. Het produkt is geïsoleerd en door 
middel van 13C-NMR- en IR-spectroscopie gekarakteriseerd als 8-fenyl-
xanthine. De oxidatie van deze verbindingen verloopt bijzonder langzaam. 
Daarom zijn slechts de ongesubstitueerde en de p-methyl- en de p-broom-
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8-arylhypoxanthines uitvoerig bestudeerd. Verhoging van de pH leidt tot een 
aanzienlijke toename van V m a x . Verhoging van de temperatuur leidt tot een 
toename van zowel V m a x als Km. 
Hoofdstuk 5 bevat de resultaten van het onderzoek naar de remming 
van vrij xanthine-oxidase met 8-arylhypoxanthines. De 8-arylhypoxanthines 
remmen xanthine-oxidase aanzienlijk bij zeer lage concentraties. Daardoor 
heeft de enzymatische oxidatie van de remstof, zoals beschreven in 
hoofdstuk 4, een grote invloed op de werkelijke concentratie. Dit effect 
verstoort de nauwkeurige meting van de Kj waarde. Daarom worden in 
hoofdstuk 5 alleen de I50 waarden vermeld. Hoewel 8-arylhypoxanthines het 
enzym reeds remmen bij equimolaire concentraties, zijn ze uiteindelijk als 
remstof net zo effectief als 6-arylpteridin-4-onen. De 150-waarden van de 
8-arylxanthines zijn vrijwel gelijk. 
In hoofdstuk 6 worden de remmende eigenschappen van 6-aryl-
pteridin-4-onen en 8-arylhypoxanthines vergeleken met die van enkele 
andere azaheterocyclische verbindingen. De plooibaarheid van het actieve 
centrum van xanthine-oxidase wordt bevestigd, doordat verbindingen, die 
aanzienlijk in grootte variëren, goed blijken te worden gebonden. Dit wordt 
aangetoond door de remmende werking van een kleine verbinding als 
allopurinol, en van grotere verbindingen als de 6-arylpteridin-4-onen en de 
8-arylhypoxanthines, en van ïin-naphthoxanthine dat twee keer zo groot is 
als allopurinol. 
Met deze gelijksoortige reeksen van verbindingen kan men tevens de 
"wanden" van het actieve centrum van het enzym bestuderen. De interactie 
van de substituenten van de 6-arylpteridin-4-onen en de 8-aryl(hypo-)xan-
thines met de wand van het actieve centrum van xanthine-oxidase lijkt 
alleen bepaald te worden door sterische factoren. Dit komt tot uiting in de 
afwezigheid van elektronische parameters (o) in de QSAR-vergelijkingen. De 
type-I- en type-II-bindingsmodellen verklaren de grote verschillen in 150-
waarden voor de 8-arylhypoxanthines en de 8-arylxanthines. Hoewel deze 
verbindingen een vergelijkbare chemische structuur hebben, is hun aryl-
groep met verschillende delen van het actieve centrum in contact. 
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